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CHAPTER I 
INTRODUCTION 
Breathing is a mechanical process that depends on precise timing of neurological systems 
and respiratory muscle function. Most of the smooth muscle that line the respiratory tract 
receive efferent signals from respiratory centers in the "medullary neural networks and 
sensory reflex mechanisms" of the central nervous system (Rundell, Wilber, Lemanske, 
2002). Accordingly, the thoracic cages' skeletal muscles responsible for inspiration 
include the diaphragm, external intercostals, sternocleidomastoid, anterior serrati and 
scalenes. Expiration is accomplished through passive relaxation of the aforementioned 
musculature coupled with the active contraction of the abdominal recti, the internal 
intercostals and other abdominal components (Guyton & Hall, 2000). These muscles, 
through sympathetic and parasympathetic input, must act together to efficiently move air 
in and out of the lungs in a normal at rest environment as well as under physically 
strenuous conditions. If the synergistic relationship between smooth and skeletal muscle 
is not harmonious, oxygen becomes depleted in the system and resultant physiological 
repercussions occur such as dyspnea, cyanosis and other pulmonary disorders (O'Connor, 
2001). 
Dynamic requirements on the breathing process that occur in sports and physical activity 
can become compromised, if not seriously impeded, in obstructive disorders and 
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pulmonary pathology (Guyton & Hall, 2000). A majority of breathing adaptation will 
occur without active control through parasympathetic contraction or relaxation of smooth 
muscle in the respiratory tract. However, to accommodate oxygen needs, skeletal 
muscles of respiration are recruited to inspire, opening the thorax and creating a 
decreased intrathoracic pressure which draws ambient air into the pleural cavity. Once 
the air has reached the alveoli and gas exchange has occurred, the residual air must be 
forcefully eliminated. Therefore, external muscles of expiration contract to create an 
increased pleural pressure thus forcing air out the respiratory tract (Guyton & Hall, 2000, 
McArdle, Katch and Katch, 1996). There are many timely and intricate actions that take 
place to allow for efficient breathing. If any structural or neurological pathology impedes 
this process, subsequent breathing disorders will arise, including inflammatory diseases 
and chronic obstructive disorders such as asthma (O'Connor, 2001). 
Asthma is a chronic respiratory disorder "characterized by spastic contraction of the 
smooth muscle in the bronchioles, which causes extremely difficult breathing" (Guyton 
and Hall, 2000). In most cases, asthma is an inflammatory condition that reacts with 
heightened sensitivity to environmental triggers such as dust, pollen, chemicals, and other 
common allergens. In some cases, increased physical activity that causes a 
corresponding increase in minute ventilation and intake of ambient air may provoke 
bronchiolar hyperactivity and induce asthmatic constriction (Rundell, Wilber, Lemanske, 
2002, Rupp, 1996). 
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Exercise-induced asthma (EIA), also referred to as exercise-induced bronchospasm or 
exercise-induced bronchoconstriction (EIB), is a physiological disorder of the respiratory 
system. It is typically characterized by coughing, wheezing, excessive sputum 
production, tightness of the chest and general dyspnea. These symptoms either occur 
minutes into strenuous activity, or they follow minutes after extended periods of physical 
exertion (Pinkowish, 2000, Lacroix, 1999, Rupp, 1996). Some authors have cited a 
range consisting of five to fifteen minutes following an exercise bout as the most 
susceptible time for symptoms to present (Houglum, 2001, Lacroix, 1999). An acute 
episode typically involves the release of inflammatory mediators system such as 
histamine, leukotrienes and prostaglandins. These mediators have local and general 
effects in the system such as bronchial wall edema formation, mucous plug formation, 
smooth muscle contraction and hypertrophy. It has been stated that long-term, aerobic-
type activities such as running, cycling, and swimming are more prone to eliciting EIA 
symptoms, but no clear connection has been found supporting such a case (Rundell & 
Jenkinson, 2002). Exercise in cold dry air or air contaminated with noxious chemicals 
and closed environments such as ice skating arenas have been indicated as predisposing 
factors to EIA presentation {Tikkanen & Helenius, 1994, Strauss, et al., 1977, Gotshall, 
2002, Fowler, 2001, Barfield & Michael, 2002, O'Kane & Woodford, 1999). 
Although the exact etiology of EIA is unknown, many theories have been postulated as to 
explain this respiratory dysfunction. The two more widely accepted theories include the 
hyperosmolarity and thermal hyperemia theory. The hyperosmolarity theory describes a 
process of mucosal cell dehydration due to excessive ventilation of air that dries out the 
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epithelial cell lining increasing the osmolarity of thes~ cells and thus provoking 
bronchoconstriction. The thermal hyperemia theory revolves around evaporation of 
cellular water following exposure to cold, dry air. A reflex vasodilation of the respiratory 
vasculature causes a transitory re-warming of the epithelial cells. The rapid flux of blood 
to the bronchial capillary beds initiates pro-inflammatory mediators that cause increased 
vascular permeability. An accumulation of edema within the structure of the bronchial 
walls ensues thereby limiting the diameter of the respiratory airways (Rundell, Wilber, 
Lemanske, 2002). 
Nearly 90% of persons with asthma also suffer from EIA (Gotshall et al. 2000, 
Mickleborough, et al., 2003), causing a confounding mixture of symptomology and 
diagnosis. The difficulty in differentiating independent EIA from chronic asthma has 
caused many physicians to opt for extensive laboratory tests which typically involve 
expensive equipment and lab work. Symptoms associated with both chronic asthma and 
exercise-induced asthma such as bronchiolar hyperresponsiveness (BHR) tend to 
confound an accurate differential diagnosis causing confusion when selecting the specific 
treatment. Other EIA symptoms cited on medical history questionnaire that bear 
similarities with chronic asthma include abnormally tiring before fellow teammates, 
excessive drying of airways due to "mouth breathing" and lightheadness (Lacroix, 1999, 
Rupp, 1996). Diagnosis of exercise-induced asthma typically is conducted in a clinical 
setting such as a hospital or respiratory healthcare facility after a patient begins to 
experience the aforementioned dyspnic symptoms specifically following exercise 
(Hansen, 1982). Graded exercise challenges, bronchiolar provocation test using irritants 
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such as methacholine, and eucapnic voluntary hyperpnoea procedures have been used to 
identify exercise-induced asthma (ACSM, 2000, Rupp, 1996, Anderson, et al. 2001) 
According to the American Thoracic Society (1994), assessment of asthmatic conditions 
requires baseline spirometric measures including FEV-1, Forced Vital Capacity (FVC) 
and Peak flow being acquired. Protocol for diagnosing EIA involves engaging the patient 
in an exercise challenge on an exercise modality such as a stationary bicycle or treadmill. 
The duration should be long enough for an appropriate assessment of pulmonary 
mechanics. It is important to note that presentation of symptoms are not necessary as 
pulmonary measures generally indicate the presence of an obstructive disorder (American 
Thoracic Society, 2000). During an exercise challenge, measures are periodically 
recorded according to a pre-established protocol and continued for approximately 20-30 
minutes post exercise. If at any time during or following the exercise bout, the FEV -1 
falls between 10-15% below baseline measures, the patient is typically diagnosed with 
EIA (ACSM, 2000, Hansen, 1996, Rundell, Wilber, Lemanske, 2002, Rupp, 1996). 
Much confusion remains for many investigators and medical practitioners regarding 
which form of asthma, if not both, an individual suffers. It is difficult to accurately 
differentiate EIA, a treatable transitory affliction, from chronic asthma due to their 
similar presentation of subjective symptoms and objective signs. Some authors (Rundell, 
Judelson & Williams, 2002) have stated that more accurate diagnosis of chronic asthma 
involves the inhalation of a bronchial irritant such as methacholine to exacerbate 
symptoms. Individuals who exhibit exercise-induced bronchoconstriction in response to 
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physical activity and no other chronic asthmatic symptoms can with assuredness be 
diagnosed through an exercise challenge (Rupp, 1996). 
Impulse oscillometry (IOS) has been recognized as a viable diagnostic tool in the clinical 
community for accurately assessing lung obstruction arising from disorders such as 
asthma and related conditions (Klinnert, Larsen, Liu, 2003, Witt, Clark, 2002, Fischer, et 
al., 1999). Like other pulmonary function tests, the patient is asked to breathe normally 
through a mouthpiece connected to a heated pneumotach. As the patient ventilates, an 
impulse-generated waveform is transmitted into the airways and the reflection of these 
sound waves is recorded, providing a measure of the lung resistance and reactance. 
The primary objective of any pharmacologic treatment of EIA is to improve 
bronchodilation through the decreasing inflammation and subsequent edema formation 
instigated by allergen or other triggers. Immediate treatment of exercise-induced asthma 
has traditionally centered on pharmacologic intervention with primarily short-term 
treatment with fast-acting bronchodilators such as beta-2 agonists including albuterol, 
bitolterol, pirbuterol and terbutaline (Houglum, 2001 ). This treatment option of a fast 
acting beta-2 agonist actually serves as a diagnostic tool for many physicians. EIA 
symptoms typically resolved quite efficiently with the short-acting agent whereas chronic 
asthma sufferers tend to need more elaborate treatment modalities (Rupp, 1996, LaCroix, 
1999). Long-acting pharmacological agents such as salmetrol (a Beta-agonist), cromolyn 
sodium, Nedocromil sodium, corticosteroids, oral theophylline, and montelukast prevent 
the onset, shorten the duration, and/ or attenuate the symptoms associated with 
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bronchospasm (Lacroix, 1999, O'Kane, Woodford, 1999, Peroni, et al., 2002, Backer, 
2002). 
Many researchers and healthcare practitioners have recommended exercise as a potential 
mode of prevention for individuals suffering from exercise-induced asthma. 
Theoretically, increasing one's ability to reach maximal ventilatory rates and volumes 
decreases the impact and magnitude of EIA-related symptoms such as bronchospasm and 
constriction (Rupp, 1996, LaCroix, 1999, Barfield & Michael, 2002, Fowler, 2001, 
Carlsen & Carlsen, 2002, Sinha, 2003, Disabella & Sherman, 1998, Satta, 2000). 
Respiratory muscle training has been investigated quite extensively on healthy, non-
pathological subjects (Tzelepis, et al., 1994 Pardy, et al., 1998, Caine and McConriell, 
1998, Inbar, et al., 2000, Chatham, et al., 1999, O'Kroy and Coast, 1993) as well as in 
other studies whose subjects suffered from such disorders as chronic asthma, emphysema 
and other forms of chronic obstructive pulmonary disorders (COPD) (Nield, 1999, 
Ramirez, et al., 2002). The theoretical underpinning of many of the aforementioned 
studies using pathological populations was to treat dyspnic, disordered breathing. By re-
training neuromuscular control of the respiratory musculature, it was hypothesized that 
subjects could essentially return to a normal, efficient breathing rate and quality. A 
review of studies which targeted the respiratory- and endurance-enhancing benefits of 
respiratory training revealed a significant treatment effect on many pulmonary measures 
including an increase in general cardio-respiratory performance and endurance 
(Amonette and Dupler, 2001, Volianitis, et al., 2001). 
7 
Respiratory training devices have become commonplace in the endurance sport market 
(PowerLung®, Sportsbreather®). Most manufacturers claim that these devices restrict 
the amount of airflow either being inspired, expired or both. lbrough modulation of 
airflow, it is theorized that increased forces will be required to generate inspiration and 
expiration against specific resistance, thus eliciting the overload and progressive 
resistance exercise (PRE) principles. Both of these notions explain the building of 
skeletal muscle strength and hypertrophy through repeated increased force generation 
(McKardle, Katch &Katch, 1996). Use of such devices in clinical investigations (Pardy, 
1998, Leith &Bradley, 1976, O'Kroy & Coast, 1993, Amonette & Dupler, 2001, 
Chatham, et al., 1999, Caine & McConnel, 1998) have produced significant results, 
prompting manufacturers to claim that it can optimize lung power, improve 
cardiovascular endurance, boost stamina, and decrease the subjective feeling of 
exhaustion (SportsBreather®, 2003). 
PURPOSE OF STUDY 
The purpose of this study is to determine if loading the respiratory skeletal musculature 
using a resistive respiratory training device will significantly decrease both subjective 
and objective respiratory measures arising from exercise-induced asthma. Exercise-
induced asthma is a relatively common condition that affects physically active people at 
all levels. Although it may not be a debilitating disease like its associated chronic 
asthma, it has the ability to limit an individual's pulmonary function following exercise 
by inducing a hyperactivity of the bronchial airways. Traditionally, palliative treatment 
has consisted of pharmacologic intervention whereas non-pharmacologic modes of 
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preventative treatment have been encouraged yet seldom researched. By utilizing 
objective diagnostic measures, there is potential for another mode of treatment for EIA 
that could be used by athletes and the general population who suffer from this respiratory 
restrictive disorder. 
HYPOTHESES 
Hl: There will be an increased positive effect on baseline (pre-training) pulmonary 
function test measures of the experimental group when compared to the control 
group following a five (5) week training regimen utilizing a resistive respiratory 
training device and protocol. 
H2: There will be a positive effect in pulmonary mechanical response after exercise 
stress testing within the experimental group when compared to the control group 
following a five (5) week resistive respiratory training device and protocol. 
H3: There will be a decreased sense of exertion measured by perceived modified Borg 
scale scores within the experimental group when compared to the control group 
following a five (5) week resistive respiratory training device and protocol. 
H4: There will be no change in the experimental group's post-exercise 
stress testing measures of pulmonary resistance including magnitude of 
respiratory impedance (Z5), total respiratory resistance (R5), proximal respiratory 
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resistance(R20) and distal capacitive reactance (X5) following a five (5) week 
resistive respiratory training device and protocol. 
H5: There will be a positive increase in the experimental group's values on post-
exercise stress testing expiratory measures (FEV-1, FEV25%-75%, Pex) following 
a five (5) week resistive respiratory training device and protocol. 
DELIMITATIONS 
1. Subject population will consist of trained individuals as represented by their 
membership on a collegiate athletic team. 
2. The subject pool will consist of several sports characterized generally as aerobic 
and anaerobic. 
3. Subjects will be at different points of their respective competitive year. 
4. Testing procedures will take place in a controlled environment using a treadmill. 
5. All individuals will be diagnosed with EIA, but will not be differentiated between 
sole exercise-induced asthma and chronic asthma. 
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6. Gender, group, age and height will be recorded and the contributing variability 
will be controlled for through randomized assignment of subjects to experimental 
and control groups. 
LIMITATIONS 
1. Subjects in this study were all trained athletes. The results of this investigation 
cannot be applied to the general population. 
2. The treatment regimen is constructed so that the individual subject must control 
their compliance with the protocol. 
3. Treatment protocol involves the unsupervised use of the respiratory training 
device during the treatment period. 
4. Subjects could potentially be taking long-term prescription medication for 
asthmatic conditions at the time of study. Long-term prescription medication 
regimens will not be interrupted and will be continued through duration of the 
study. 
ASSUMPTIONS 
1. Subjects will comply with resistive respiratory training with device for 
extent of five (5) weeks. 
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DEFINITION OF TERMS 
AIRWAY HYPERRESPONSIVENESS: describes airways that narrow too easily or too 
much in response to a provoking stimulus. In asthma, airways can be hyper responsive to 
many different stimuli (American Medical Association, 2003). 
ALLERGEN: a protein that causes one to have an allergic reaction. Examples include 
foods, animal dander and some drugs (Guyton & Hall, 2000). 
ASTHMA: a chronic inflammatory disorder in which many cells play a role, in 
particular mast cells, eosinophils and T lymphocytes. In susceptible individuals this 
inflammation causes recurrent episodes of wheezing, breathlessness, chest tightness and 
cough particularly at night and/or in the early morning. These symptoms are usually 
associated with widespread, but variable airflow limitation that is at least partly reversible 
either spontaneously or with treatment. The inflammation also causes an associated 
increase in airway responsiveness to a variety of stimuli. (AMA, 2003) 
BRONCHOCONSTRICTION: airflow limitation due to contraction of airway smooth 
muscle (Guyton & Hall, 2000). 
BRONCHOSPASM: narrowing of bronchial tree tubes including the bronchi and 
bronchioles typically due to involuntary smooth muscle contraction (Guyton & Hall, 
2000). 
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CHRONIC AIRFLOW LIMITATION: synonymous with Chronic Obstructive 
Pulmonary disorder (COPD). Disease state that restricts airflow entering and exiting the 
respiratory system (Rundell, Wilber & Lemanske, 2002). 
DYSPNEA: dysfunctional or painful breathing (American College of Sports Medicine, 
2000). 
EDEMA: Residual collection of fluid in the capillary bed that permeates through the 
vessel wall into the interstitial space (Guyton & Hall, 2000). 
EFFERENT: Motor neurons that carry impulse away from the brain causing an effect 
(McArdle, Katch and Katch, 1996). 
EMPHYSEMA: A complex obstructive and destructive process causing excess air in the 
lung tissue (Guyton & Hall, 2000). 
EXERCISE CHALLENGE TEST: graded exercise test used to assess pulmonary 
function and possible markers of pathology (ASCM, 2000) 
FORCED VITAL CAP ACITY(FVC): maximal volume of air exhaled with maximally 
forced effort from a position of maximal inspiration (American Thoracic Society, 2002). 
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FORCED EXPIRATORY VOLUME IN ONE SECOND (FEV-1 ): volume of air 
maximally exhaled in the first second of a forceful breath; typically 75% of the forced 
vital capacity (American Thoracic Society, 2002). 
HYPEREMIA: An increased rate of blood flow to a tissue causing a cutaneous redness 
(Guyton & Hall, 2000). 
HYPEROSMOLARITY: An increased concentration of particles (ie. ions) in solution 
(McArdle, Katch and Katch, 1996). 
HYPERPNEA: Increased ventilation typically brought upon by exercise (McArdle, 
Katch and Katch, 1996). 
IMPULSE OSCILLOMETRY: Diagnostic means of identifying pulmonary impedance 
and resistance through varying frequencies of pressure impulses (Jaeger-Tonnies, 2003). 
LARYNX: Component of respiratory passageway that houses the vocal cords (Guyton & 
Hall, 2000). 
INSPIRA TORY MUSCLE TRAINING: increasing load or time of exercise on skeletal 
musculature controlling inspiration thus producing results of increased strength and 
endurance (Pardy, R.L., Reid, W.D., Belman, M.J., 1988). 
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FORCED EXPIRATORY VOLUME 2so/o-7s%: mean forced expiratory flow during the 
middle half of the forced vital capacity (American Thoracic Society, 2002). 
LUNG REACTANCE: the elasticity and mass inertia of the airways, lung tissue, thorax, 
and the inertia of the air within the bronchi (Finucane, K.E., Dawson S.V, Phelan, P.D., 
Mead, J., 1975). 
LUNG RESISTANCE: summative restrictive forces created by the structure and 
function of the lung tissues airways (Finucane, K.E., Dawson S.V, Phelan, P.D., Mead, J., 
1975). 
MEDULLA OBLONGATA: Lower area of brain that controls respiration (Guyton & 
Hall, 2000). 
NASOPHARYNX: cavity between nasal passage and primary air route of throat (Guyton 
& Hall, 2000). 
PEAK EXPIRATORY FLOW: largest expiratory flow achieved with a maximally 
forced effort from a position of maximal inspiration. (American Thoracic Society, 2002). 
PONS: component of mid-brain that aids in auto-regulatory control of breathing 
(Guyton & Hall, 2000). 
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RESIDUAL VOLUME: volume of air remaining in lungs after the most forceful 
exhalation (Guyton & Hall, 2000). 
SPIROMETRY: medical test that measures the volume ( or changes in volume of air) an 
individual inhales and exhales as a function of time (American Thoracic Society, 2002). 
TOT AL LUNG CAP A CITY: maximum volume to which the lungs can be expanded 
with the greatest possible effort (Guyton & Hall, 2000). 
TIDAL VOLUME: total volume of air inspired or expired with each normal breath. 
(Guyton & Hall, 2000). 
TURBINATES: small indentures in nasal cavity that produces eddying currents of 
passing air (Guyton & Hall, 2000). 
VASODILATION: Vessel opening becoming larger allowing for increased flow 
(Guyton & Hall, 2000). 
VITAL CAP A CITY: the maximal volume of air exhaled from the point of maximal 
inhalation or the maximal amount of air inhaled from a point of maximal exhalation 
(American Thoracic Society, 2002). 
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CHAPTER2 
REVIEW OF THE LITERATURE 
This chapter will review the anatomical and physiological relationships within the 
pulmonary system and the disorders, specifically exercise-induced asthma, that can 
adversely affect it. Content also will describe the effect of resistive respiratory muscle 
training through a comprehensive review of the literature. 
Physiology of Breathing 
Breathing is a critical, life-sustaining process both at rest and with increased physical 
activity (Wilmore & Costill, 1994, Powers & Howley, 2001). The mechanical process of 
transporting ambient air in and out of the lungs is commonly referred to as ventilation. 
As muscles surrounding the thorax contract and relax, the thoracic cavity which houses 
the lungs is constantly changing the amount of available gaseous space (Guyton & Hall, 
2000). Through pressure gradients and the aforementioned muscular control, air is 
moved into the lungs where an exchange of gaseous oxygen and carbon dioxide occur. 
Partial pressures of oxygen and carbon dioxide between lung tissue and the nearby 
capillary beds cause a "diffusion process called respiration" (O'Connor, 1994, p. 59). 
Oxygen is transported through the alveolar walls and into the blood stream destined for 
cellular respiration while carbon dioxide is moved into the lung space for subsequent 
elimination from the body (Guyton & Hall, 2000). 
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Neural control of this process involves a cascade of impulses being sent from the medulla 
oblongata and pons of the midbrain initiating a contraction of inspiratory muscles. 
Primarily, the diaphragm and external intercostals but, when increased ventilation is 
required, recruit the stemocleidomastoid, anterior serrati and scalene to expand the rib 
cage and increase the intrathoracic space (Guyton & Hall, 2000). Interestingly, the lungs 
are not directly attached to the rib cage, but rather encased in pleural sacs containing fluid 
that aids in decreasing friction between the lungs and rib cage during respiration. These 
sacs are, attached to the thoracic cage so the pleural cavity does adjust and conform to the 
dynamic space of the chest cavity (Wilmore, Costill, 1994). The enlargement of the 
thoracic cavity creates a negative pressure in relation to the external atmospheric pressure 
and draws ambient air in through the mouth and nose into the nasopharynx. As the air is 
passed through the turbinates or cavities within the nose, the air is filtered, warmed and 
humidified as it passes into the pharynx, larynx and eventually, the trachea (Wilmore, 
Costill, 1994). Conditioned air is then divided into the respiratory tree of the lungs 
through the bilateral bronchial branches into the smaller bronchioles and terminal 
bronchioles eventually into the respiratory bronchioles and alveolar sacs. At this point of 
the respiratory zone, the one-cell-layer walls of the alveoli provide a transit system for 
gas exchange. The carbon dioxide that passively collects in the alveolar sacs is then 
conducted back through the same path as the oxygen traveled (Powers & Howley, 2001). 
It is important to note that as physical activity increases, as with exercise, the ventilatory 
rate increases to meet demands for oxygen consumption and carbon dioxide removal. 
Guyton and Hall report that with, "strenuous exercise, oxygen consumption and carbon 
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dioxide formation can increase as much as 20-fold." (2001, p.479). However, it seems 
that many other contributing factors control the rate of respiration and that chemical 
concentrations of oxygen and carbon dioxide are the not the main determinants for 
increased respiratory rate (McArdle, Katch, Katch, 1996). Also, quiet breathing, which 
normally occurs through the nasal passage at a rate of five (5) to six (6) liters per minute, 
typically changes route and rate (20-30 I/min) with increased exercise and is conducted 
through the mouth bypassing the conditioning effects of the nasopharynx (Powers & 
Howley, 2001, Guyton & Hall, 2000). These factors will play a significant role in how 
individuals who engage in exercise accommodate increased ventilation of unconditioned 
air, especially in pulmonary obstructive disorders. 
Diagnostic Measures of Lung Function 
Traditional spirometry involves the measurement of inspired and expired air through a 
flow sensitive mouthpiece (Powers & Howley, 2001). Protocols suggested by many 
authors (Rupp, 1996, LaCroix, 1999) and organizations such as the American Thoracic 
Society (1994) and ACSM (2002) consist of preliminary measures followed by an 
exercise challenge Other modes include a pharmacological challenge utilizing bronchial 
irritants such as methacholine and mannitol or an eucapnic voluntary hyperpnea (EVH). 
The "gold standard" test as described by Hallstrand, et al., (2002) involves a seven (7) 
minute exercise challenge conducted on treadmill or stationary bike at 85%-90% of 
predicted maximal heart rate followed by serial spirometry (Hansen, 1982, Lacroix, 1999, 
Fowler, 2001). LaCroix (1999) further suggests that no warm up should be allowed 
before exercise challenge as it might blunt opportune bronchospasm. Carlsen, Engh & 
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Mork (2000) conducted a study of importance in regards to exercise load when they 
found that loads that increase heart rate to approximately 95% of predicted maximum are 
more provocative of EIB. 
Typically, forced vital capacity (PVC), forced expiratory flow in one second (FEVl ), 
forced expiratory volume in 25%-75% of exhalation, and peak expiratory flow are the 
measures used to diagnose any asthmatic condition. ACSM (2000: 131) indicates that a 
fifteen (15%) percent decrease in FEV-1 during the post exercise period qualifies a 
person as having EIA. Furthermore, Fowler (2001) and Rundell (2002) categorize the 
severity ofEIA as a ten (10%) to twenty (20%) percent drop in FEV-1 being mild, twenty 
(20%) to forty ( 40%) percent being moderate, and a greater than 40% drop characterized 
as severe EIA. 
Recently, the use of lung resistance during rest has been used to quantify pulmonary 
disorders such as asthma, chronic obstructive pulmonary disorder (COPD), chronic heart 
failure and cystic fibrosis with significant success (Marotta, et al., 2003, Fischer, et al., 
1999, Witte, et al., 2002). Although methods such as body plethysmography have been 
noted to produce the most accurate measures of lung resistance, the individual being 
tested must sit in a thermally equilibrated chamber making an exercise challenge 
extremely difficult (Rundell, Wilber & Lemanske, 2002). Impulse oscillometry (IOS) 
represents a forced oscillation method to gauge lung resistance through normal tidal 
breathing. Individuals breathe normally into a mouthpiece connected to a pneumotach 
and a small loudspeaker that generates random impulses at a frequency of five to thirty-
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five hertz (5-35 Hz). These impulses are then superimposed on the normal tidal breaths 
and "real-time recordings of mouth pressure and flow are used to estimate total 
respiratory system impedance (Z) and its two components, resistance (R) and reactance 
(X)" (Ortiz & Menendez, 2002, p. 532). In light of the convenience and ease oflOS 
measurements, some authors such as Johnson, et. al. (1999) warn that such measures 
taken without a maximal inspiration might distort lung capacity volumes, thereby 
decreasing the accuracy of such measurements. However, the authors do agree with 
Marotta, et al. (2003) and Fischer, et al. (1999) that at rest, forced oscillation is a reliable 
indicator of upper versus lower airway obstruction. Furthermore, Scmekel and Smith 
(1997) conducted a study using forced oscillometry to assess frank asthma after bronchial 
provocation through isocapnic hyperventilation of dry air. The results were significant as 
the sensitivity for asthma detection through forced oscillation technique was eighty-nine 
(89%) percent and specificity for asthma was one hundred (100%) percent. 
To obtain a subjective measure of physical activity, research studies have typically 
enlisted the use of Borg's 6-20 category scale of rating perceived exertion (RPE). As 
ACSM (2002) states, the RPE, "is a valuable and reliable indicator in monitoring and 
individuals exercise tolerance" with consideration for, " ... personal fitness level, 
environmental conditions and general fatigue levels." (p. 78). Borg's original study 
conducted in 1970 produced correlative results between subject's heart rates and their 
personal estimation of exertion. As the subject's heart rate increased due to increase in 
activity level, the sensation of more strenuous work load also increased. It was concluded 
through his work and subsequent work of Russell (1997) and Robertson (1998), that the 
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RPE was a valid ins1rument for subjective estimation of perceived exertion. Borg (1982), 
further clarifies that the modified category version (appendix) of the RPE scale would be 
appropriate for determining other subjective symptoms such as breathing difficulties. 
Interestingly, Suzuki, et al. found no significant correlation between perceived exertion 
scores during exercise within subjects trained with a resistive inspiratory training device 
after a four (4) week period. However, several studies have utilized Borg's RPE scale or 
a modification thereof, (Chatham, et al, 1999, Caine & McConnell, 1998, Volianitis, 
2001) to gauge how a subject perceived an exercise challenge to be physically strenuous 
with success. 
Asthma and Effect on Lung Function 
Although many authors characterize asthma as a disease (McArdle, Katch, Katch, 1996, 
Wilmore & Costill, 1994, Powers & Howley, 2001), Lacroix (1999) explains that, 
"because people who have asthma differ with respect to provocation factors, clinical 
manifestations, disease progression, and treatment responsiveness, asthma is often 
viewed as a syndrome, rather than a unique disease entity." (p. 76). Hay fever and 
allergic rhinitis also have been closely associated with the disease (McArdle, Katch, 
Katch, 1996, O'Kane and Woodford, 1999). O'Connor defines asthma as, "an abnormal 
autonomic regulation of bronchial muscles (that) produces bronchospasm, partial airway 
obstruction, chronic bronchial inflammation and bronchial edema." (2001, p. 68). 
Lacroix (1999) attributes this hyperresponsiveness to an abundance of stimuli including 
pollen, cigarette smoke, air pollutants, cold air, viral infection, and physical exertion. 
22 
O'Kane and Woodford (1999) describe asthma as a reversible pathology with the 
elimination of such triggers or through immediate or long-term treatment. 
This chronic inflammatory airway disease presents itself through the involuntary 
constriction of respiratory smooth muscle initiated by some allergic or hyperactive 
response to a trigger. Many authors cite commonly reported symptoms of asthma as 
chest constriction, pain, respiratory fatigue and dyspnea where signs observed include 
wheezing, shortness of breath, productive or non-productive cou~ and inability to take a 
complete breath (O'Kane & Woodford, 1999, LaCroix, 1999, O'Connor, 2001). 
It has been traditionally diagnosed through a comprehensive medical history indicating 
the aforementioned symptoms or more objectively through the use of spirometry 
(Houglum, 2001, ASCM, 2001). According to accepted protocols (American Thoracic 
Society, 1994), an individual's best forced expiratory volume in the first second (FEV-1) 
and peak expiratory flow (PEF) readings are measured when symptom free and then used 
as base-lines for follow up assessment. If a drop in the FEV 1 of 10% -15% occurs, they 
are diagnosed with asthma (O'Kane, Woodford, 1999, Houglum, 2001, Backer, 2002). 
Treatment for asthma range from emergency-rescue bronchodilators such as albuterol to 
long-term control therapy that typically involves inhaled and oral medications like 
corticosteroids and leukotriene inhibitors (Houglum, 2001 ). 
The incidence and prevalence of asthma varies in regards to populations surveyed. The 
National Center for Health (2003) statistics reports that in 2001, 13.3 million people have 
reported being diagnosed with asthma within their lifetime. Kovan and Mackowiak 
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speculate that nearly seven (7) percent of the American population suffers from the 
disease (2001). Sixty (60%) percent of those indicated having experienced an acute 
asthmatic attack within the previous year. In 2000, 10.4 million outpatients' visits to 
hospitals, clinics and private doctors offices were recorded for complications arising from 
asthmatic attacks and a total of 4,487 deaths were attributed to asthma. 
Exercise-induced bronchoconstriction (EIB) and exercise-induced bronchospasm is a 
related pathology, but as Rundell, Wilber & Lemanske (2002) contend, asthma tends to 
be multifactorial, whereas the latter two terms tend to be resultant reactions to the 
condition. They cite Weilers' definition ofEIA being, "an intermittent narrowing of the 
airways, accompanied by a decrease in some measure of airflow that the individual 
experiences as wheezing, chest tightness, coughing, and/or dyspnea that is triggered by 
exercise" (2002, p. 40). Several researchers have extended this definition to encompass 
exposure to cold, dry air while exercising as one of the primary factors in EIA symptom 
manifestation (Kovan & Mackowiak, 2001, Wilber, 2002, Tikkanen & Helenius, 1994, 
Straus, et al., 1977, Sinha & David, 2003, Carlsen & Carlsen, 2002, Anderson, 2002, 
Gotshall, 2002, Folwer, 2001, Rupp, 1996, LaCroix, 1999, ACSM, 2000). As shown in 
Weiler' s definition, symptoms of EIA are remarkably similar to those of asthma, but 
generally present five (5) to fifteen (15) minutes following the completion of exercise and 
typically subside after sixty (60) to ninety (90) minutes (Wilber, 2002). Due to a similar 
presentation of symptoms and disease manifestation, Wilber (2002) has delineated 
asthmatics into three categories; individuals who have both chronic asthma and EIA 
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(90% of surveyed population), individuals who have chronic asthma, but not EIA (10%) 
and those who have EIA but not chronic asthma or allergic rhinitis (3-10%) (p.41 ). 
The term "refractory period" has been used to describe the period of time following an 
acute attack ofEIA symptoms (Rupp, 1996, LaCroix, 1999, ACSM, 2000, Anderson & 
Holier, 2002). In the several hours that ensue, an individual might experience a weaker 
(by approximately 50% or more) attack or enter into a term of remission from another 
attack due to a decreased sensitivity of the already inflamed bronchial cells. Although 
many researchers claim this buffering phenomenon to be real, Rundell, et. al. (2003) 
studied cross-country skiers during a prolonged exercise challenge and found that only 
one (1) of eighteen (18) athletes experienced a refractory period as determined by 
spirometric measurements. Hence, it is difficult to objectively determine such a 
phenomenon but clinicians and researchers continue to suggest eliciting the refractory 
period through a warm-up period prior to exercise as a preventative technique (Houglum, 
1999, Rupp, 1996, LaCroix, 1999, ACSM, 2000, Anderson & Holzer, 2002). 
Many theories have been proposed as to the origin of EIA (Anderson & Holzer, 2002), 
but two have become the more thoroughly researched and accepted. Both host as its 
primary tenets the energy-transfer effect of ventilation as air is passed over the epithelial 
layers of the bronchial tract. It has been postulated that as ambient air is warmed and 
humidified, both cellular heat and water are lost within the protective layers of the 
respiratory passageway. This pattern of thinking has led to the hyperosmolarity and 
thermal hyperemia theories. 
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Inspired environmental air passes by the airway mucosa in the nasal passages where it is 
warmed to 3 7° C and humidified with approximately 44 mg H20/L through convective air 
flow. This process of conditioning the air removes water from the mucosal layers into 
the airway lumen, thereby increasing the osmolarity of the cells. This dehydration 
creates hyperosmolar cells that promote mast cell degranulation, which is a precursor of 
inflammatory mediator release. It is thought that the release of these pro inflammatory 
agents leads to bronchoconstriction and general symptoms ofEIA (Kanazawa, et al., 
2002, Storms & Joyner, 1997, Anderson & Holzer, 2000). However, in a study using 
eight (8) atopic asthmatic subjects, McFadden, et al. (1999) found that, ''the removal of 
water from the lower respiratory tract, and by inference, the development of a 
hyperosmolar periciliary fluid, do not appear to be the primary causes of thermally 
induced asthma." (p. 223). They further contend that although water loss contributing to 
an increased osmolarity of the mucosal cells may not be the major influential factor in the 
initiation of EIA, the rapid evaporation of water does lead to loss of heat, provoking 
another form of the theory. 
Inspiration of cold dry air significantly induces evaporation of water from the epithelial 
cells within the mucosa to condition the air for transfer into the lower respiratory tract. 
This theory has been strongly supported through study of winter sport athletes such as 
skiing and running where air is typically dry and frigid (Tikkanen & Helenius 1994, 
Strauss,et al., 1977, McDonald, et al., 1997, Rundell & Jenkinson, 2002). The 
evaporation and energy transfer has a transitory cooling effect on the mucosa, initiating a 
reflexive increase in the capillary blood flow of the airway vasculature. This 
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engorgement of blood flow in the capillary network is thought to be the body's attempt to 
re-warm the bronchial tissue back to homeostatic temperature. It has been hypothesized 
that this reflexive warming actually promotes pericapillary leakage and the formation of 
airway edema thus impinging on the lumen of the airway (Anderson & Holzer, 2000, 
Rupp, 1996, McKardle, Katch & Katch, 1996). 
Other factors that have been studied regarding the severity of EIA disease have included 
the levels of nitric oxide in the respiratory epithelium (Kanazawa, et al., 2002), and the 
presence of vascular endothelial growth factor in asthmatic airways (Kanazawa, et al., 
2002). Mickleborough and Gotshall ( 2003) have reported that "dietary excess of salt, 
omega-6 fatty acids, and a dietary deficiency of anti-oxidant vitamins and omega-3 fatty 
acid, can modify the severity ofEIA" (p. 671). In fact, while studying the effects of 
dietary salts on the magnitude of the symptoms associated with EIA, separate 
investigations found that diets low in dietary salt intake showed marked improvements on 
pulmonary function tests as compared to baseline assessment. Consequently, high salt 
diets actually worsened measures (Gotshall, et. al. 2000, Mickleborough, 2001). 
The prevalence of exercise-induced asthma is somewhat confounding due to the 
multitude of factors that can affect its etiology and presentation. EIA has been reported 
to affect approximately 90% of those diagnosed with chronic asthma and 40% of those 
diagnosed with allergic rhinitis or atopic dermatitis (Wilber, 2002, LaCroix, 1999). The 
American College of Sports Medicine (2000) state the prevalence of EIA to be 
approximately ten (10%) to fifty (50%) percent depending on the sport studied, the 
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exercise protocol, diagnostic tool and environmental conditions. This large range has 
since been attenuated through other research studies quoting the general publics 
likelihood of being diagnosed with EIA to be around twelve (12%) to fifteen (15%) 
percent while active individual rates range from three (3%) to more than twelve (12%) 
percent (Rupp, 1996). Wilber (2002) points out that 11.2% of the United States athletes 
competing in the 1984 Winter Olympics were diagnosed with EIA while a staggering 
50% of cross country skiers in the 1998 Winter Olympics reported the disease. 
Interestingly, over forty medals were awarded to 1994 Olympic team members who 
happened to also be EIA sufferers supporting the notion that individuals diagnosed with 
this condition can continue competitive function. 
Differentiating EIA from chronic asthma can be best described by Storms and Joyner's 
comments (1997): "The distinction between solitary EIA and persistent asthma is best 
made by pulmonary function testing at rest. In a patient with solitary EIA, the results will 
be normal; in the results of a patient with chronic persistent asthma, pulmonary function 
will be lower than normal." (p. 3). Diagnosis of exercise-induced asthma is usually 
accomplished by conducting a thorough medical history to rule out other pathologies 
such as cystic fibrosis, chronic bronchitis, pneumonia or paradoxical vocal cord 
dysfunction (Lacroix, 1999, Koester & Amundson, 2002, Brugman & Simons, 1998). 
However, differentiating between chronic frank asthma and exercise-induced asthma will 
present any physician with a quandary as the same symptoms are seen in both 
pathologies. Coughing, wheezing, chest tightness, dyspnea, shortness of breath, excess 
mucous and respiratory fatigues are common complaints from both asthmatics and 
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victims ofEIA (Rundell, Judelson, & Williams, 2002). Therefore, history questions 
should assess respiratory symptoms associated with asthma and primarily target the 
period of time directly following cessation of exercise (Anderson, 2002). A physical 
examination will essentially reveal nothing remarkable in conditions of EIA. Some have 
documented the presence of polyps in the nasal passage, inflamed mucosa! layers, or 
drainage into the pharynx possibly due to concomitant conditions such as chronic asthma 
(LaCroix, 1999, Rundell, Judelson, & Williams, 2002). Most physicians will opt for 
pulmonary function tests that include spirometry and, more recently, impulse 
oscillometry (Rupp, 1996, Marotta, et al., 2003). 
Treatment for Exercise Induced Asthma 
Historically, exercise-induced asthma has been treated through pharmacological and non-
pharmacological means. In reference to the acute bronchoconstriction commonly 
associated with the period following an exercise bout, fast-acting rescue bronchodilators 
have actually been used to ameliorate the dyspnic symptoms. In diagnostic medicine, 
these agents have been used to differentiate between EIA and chronic asthma. It has 
been found that dyspnic symptoms following exercise typically cease when treated with a 
B- agonist inhaler whereas frank asthma tends to require more comprehensive 
pharmaceutical treatment (LaCroix, 1999, Anderson, 2002). These inhaled medications, 
or beta-2 agonists, act on the beta adrenergic receptors of the smooth muscle cells within 
the bronchial tract to induce bronchodilation. Medicinal effects usually occur within five 
(5) minutes of being administered and typically last for four (4) to eight (8) hours. When 
used to prevent symptoms of EIB, beta-2 agonists host effects for only half of that time, 
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or two (2) to four ( 4) hours post administration (Houglum, 200 I). Although a limit has 
not been established on how many standard canisters one should use to treat episodes of 
bronchoconstriction per day, Anis, et al. (2001) reported that when investigating current 
trends in asthma therapy, four ( 4) canisters per day would not be excessive. However, 
this repeated usage poses another problem, that of desensitization to the drug. Hancox, et 
al. (2002) found that when studying eight (8) subjects diagnosed with EIB, ''regular B-
agonist treatment leads to increased exercise induced bronchoconstriction and a 
suboptimal bronchodilator response to B-agonist." (p. I 068). This is further supported by 
Anderson (2002) who states that, "B2- agonists are not the most suitable therapy for 
preventing EIA if they need to be used on a daily basis."(p. S61). 
Long-term therapeutic agents ranging from inhaled corticosteroids (National Asthma 
Education and Prevention Program, 2002), inhaled heparin (Tahir, et al., 1993), oral 
montelukast (Peroni, 2002), salmeterol (Nelson, et al., 1998), sodium cromglycate and 
Nedocromil sodium (Backer, 2002) have had significant effects when treating EIA. 
These pharmaceuticals are meant to be taken on a strict treatment regimen to prevent an 
acute attack and should not be viewed as rescue agents (Houglum, 2001, O'Kane & 
Woodford, 1999). 
Although contemporary medicine has provided for such advances in pharmacological 
intervention for the treatment of EIA, studies have shown that patient education and 
prescription drug adherence is less than desired. Interestingly, patient compliance with 
long-term therapies has not been good with some authors quoting less than fifty (50%) 
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percent compliance (NAEPP, 2002). Anis, et al. (2001) attributes this poor compliance 
rate to improper medication use and poor patient education, a common fault in many 
asthma control programs (NAEPP, 2002). 
In addition to eliciting the refractory period with a well timed warm up period (ACSM, 
2001 ), many authors have suggested physical conditioning to prevent or attenuate future 
EIA episodes (Carlsen & Carlson, 2002, Fowler, 2001, Barfield & Michael, 2002, 
LaCroix, 1999, Satta, 2000, Diabella & Sherman, 1998). It is hypothesized that 
increased aerobic fitness will increase an individual's ability to work at a "lower vital 
capacity, decreasing the cooling and drying stimuli, resulting in less bronchospasm" 
(Sinha, 2003, p. 770). Rupp (1996) lends further support for this mode of treatment 
stating that, "Management should begin with efforts to increase physical conditioning, 
which can reduce the requirements for pharmacotherapy and decrease the incidence of 
asthma attacks." (p. 5). 
Respiratory muscle training 
It is a standing physiological feat that skeletal muscle hypertrophies and becomes more 
neurologically trained when engaged in periodic bouts of increased resistance exercise. 
This natural causal model presents the fundamental underpinnings of strength training as 
it stands today (McArdle, Katch and Katch, 1996). In many instances, skeletal muscle 
strengthening is used to increase muscle mass and function for improved performance. 
Some individuals might employ resistive training to compensate for a debilitating injury 
or pathological deficiency where an individual might have to re-train the neuromuscular 
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pathways and re-establish pre-injury muscle tone. Either way, the overload and the 
Progressive Resistance Exercise (PRE) principles govern the notion of muscle training 
and its subsequent hypertrophy. Both of these accepted theories incorporate placing 
above normal stresses on muscle tissue which will in turn produce gains in muscle fiber 
strength and diameter (McArdle, Katch and Katch, 1996). 
A majority of the studies conducted thus far on respiratory muscle training have 
concentrated on inspiratory muscle training on those groups afflicted with some 
pulmonary pathology that somehow restricts airflow. The common factors in these 
studies tend to focus on muscular strength and endurance gain through resistive 
inspiratory breathing. Lotters et al. (2002) support these points when they performed a 
meta-analysis of several studies conducted on inspiratory muscle training for patients 
diagnosed with COPD. They summarize their findings by reporting that, "both 
inspiratory muscle training alone and inspiratory muscle training as adjunct to general 
exercise reconditioning significantly increase inspiratory muscle strength and 
endurance." (p. 570). 
Interestingly, a number of investigations performed with a pathological population 
utilized a methodology consisting of a moderately small (typically less than 30) subject 
population and a training period that ranged from weeks to months. 
In two separate studies Lisboa, et al. (1994), investigated the effects ofinspiratory muscle 
training (IMT) in patients diagnosed with chronic airflow limitation (CAL), characterized 
as a deficit of~30% in forced expiratory volume in one second. In the first, Lisboa, et al. 
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(1994), found that while studying twenty (20) subjects, the experimental group (n=IO) 
that was trained using an inspiratory load equal to thirty (30%) percent restriction of flow 
showed a greater increase in markers of inspiratory muscle strength and exercise 
endurance compared to a control group that used a respiratory device that restricted 
twelve (12%) percent inspiratory flow. Subjective measures of dyspnea also decreased 
over the five (5) week training period in the experimental group. Both groups trained on 
their respective devices for thirty minutes per day for a total five (5) weeks. In the 
second study, inspiratory training devices hosting a thirty (30%) percent resistance in 
peak inspiratory flow resulted in improved measures of dyspnea, increased exercise 
capacity and reduced the metabolic cost of exercise. Subjects were trained for thirty (30) 
minutes per day, six (6) days per week for ten (10) weeks (Lisboa, et al., 1997). 
In a series of studies investigating the effects of inspiratory muscle training on patients 
diagnosed with chronic obstructive pulmonary disorder, subject populations ranged from 
four ( 4) (Nield, 1999), eleven (11) (Goldstein, et al., 1989), thirteen (13) (Chen, Dukes, 
Martin, 1985), fourteen (14) (Ramirez, et al., 2002), and thirty (30) (Scherer, et al., 2000). 
Treatment for inspiratory training consisted of one (I) (Nield, 1999, Ramirez, et al., 
2002) to two (2) (Goldstein, et al., 1989, Scherer, et al., 2000, Chen, Dukes, Martin, 
1985) separate sessions per day for variable number of days (five to seven) within four 
(4) (Goldstein, et al., 1989), four (4) (Chen, Dukes, Martin, 1985), five(5) (Ramirez, et 
al., 2002), six (6) (Nield, 1999), and eight (8) (Scherer, et al., 2000) week periods. 
Goldstein et. al. (1989), Chen, Dukes & Martin (1985), and Scherer et al., all found that 
IMT increased inspiratory muscle endurance and decreased sensation of dyspnea after 
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treatment with a device capable of thirty (30%) percent or more restriction. Additionally, 
Nield (1999) found that IMT increased muscular strength, as measured through 
inspiratory force generated, as well as decreased dyspnic scores of COPD. 
A noteworthy study conducted by Weiner, et al. (1998) involved patients undergoing 
coronary artery bypass surgery. Historically, this surgery left patients with depressed 
respiratory function that extended the time of hospitalization post surgery. In the study, 
forty-two ( 42) patients underwent prophylactic IMT for two (2) weeks one month prior to 
surgery. When compared to a control group (n=42) of similar patients, the experimental 
group maintained significant respiratory function post operation as indicated by 
pulmonary function tests, respiratory muscle function and gas exchange measures. 
Although no studies were found specifically focusing on exercise induced asthma, several 
investigations composed of frank asthma patients were reviewed. In two separate studies, 
Weiner, et al. (1992) found that specific inspiratory muscle training conducted for six (6) 
months on mild asthmatics resulted in decreased dyspnic scores and decreased beta (2) 
agonist consumption. Weiner further supported these :findings in two other independent 
studies that spanned over 3 (Weiner et al., 2000) and 4 months (Weiner et al., 2002) using 
IMT. 
Resistive respiratory muscle training has not been reserved to treatment of the clinical 
population, but also has been used with marked success in healthy subjects as well. 
Pardy, Reid, & Belman (1988) indicate in a review of studies conducted on healthy 
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individuals, respiratory muscle training does offer marked improvement in muscle 
strength and endurance. They did conclude that although improvements were observed, 
methodological shortcomings such as subject population number and training method 
were present and should be corrected for in future studies. Improvements in respiratory 
function credited to inspiratory muscle training (IMT) typically include change in lung 
capacity, pressure generation, and rate of ventilation. However, Sheel (2002) agrees with 
Pardy, Reid & Belman, stating that studies conducted thus far, on these highly specific 
measures alone, provide a tenuous argument in correlating respiratory muscle training to 
improve exercise performance. Methodological shortcomings including small population 
sizes and the use of an inappropriate control group were the main areas of contention for 
study design inadequacy. Coincidentally, the author explained that possible reasons for 
the improved measures observed in exercise performance within these reviewed studies 
include a decrease in improvement in breathing perception, delayed fatigue of respiratory 
musculature and improved ventilatory efficiency. Chatham, et al. (1999) reason that 
these logistical faults in study execution has pre-empted the inclusion of respiratory 
muscle training in everyday clinical practice. 
In 1976, Leith and Bradley were quoted as saying, "Many observations suggest that 
normal human ventilatory muscle capacities can be increased by approximate stimuli. 
But we found no adequate studies of ventilatory muscle training which employed direct 
measures of strength and endurance ... " " ... nor studies which applied accepted principles 
of strength and endurance training specifically to the ventilatory muscles, either in 
normal humans or in persons with respiratory disease." (p. 508). The study they 
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subsequently conducted involved three treatment groups ( strength training, endurance 
training and a control group) that underwent a training period of five (5) weeks. It was 
found that the strength training group increased their ability to generate maximal 
inspiratory pressure by fifty-five (55%) percent. Likewise, endurance training improved 
sustained ventilation as measured by maximal voluntary ventilation (MVV) by more than 
fifteen (15%) percent. It was concluded from this pioneer study that individuals can 
increase specific ventilatory measures that correspond with respiratory muscle strength 
and endurance. 
O'Kroy & Coast (1993) and Amonette & Dupler (2001) concur with these observed 
results in similar studies. Following a four (4) week training period, O'Kroy and Coast 
found that endurance training improved both flow and resistive markers as measured 
through spirometry while strength training affected strength and resistive test measures. 
Likewise, Amonette and Dupler used a respiratory training device that restricted airflow 
by more than thirty (30%) percent normal ventilation rates over a four-week training 
period. Specific percentages were subjectively selected according to perceived flow 
exertion. During this treatment, experimental group members performed thirty (30) 
inhalation and exhalation maneuvers on the device two (2) times per day. Investigators 
found that when compared to the control group, resistive respiratory training improved 
maximal and sub maximal ventilation, peak exhalation flow test and maximal tidal 
volume. Although no significant changes were seen in pulmonary mechanics such as 
PVC, FEV-1, peak expiratory flow, the authors suggest that because pulmonary muscles 
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adapt to aerobic exercise, as in the case with the specific study population, smaller (less 
significant) changes and differences would be seen after respiratory training. 
Several studies have since focused their respective methodologies and investigated the 
benefits of specific inspiratory training on pulmonary :function. While studying twenty-
two (22) subjects using an incremental inspiratory muscle training program, Chatham, et 
al. (1999) discovered that the experimental group improved respiratory muscle strength 
and endurance, metabolic cost of ventilation and predicted maximal oxygen consumption 
(V02 maximum) over a ten (10) week treatment period. Additionally, Suzuki, et al. 
(1993) and Caine & McConnell (1998) also found that experimental groups training with 
an inspiratory training device that restricted a percentage (range of 30%-40%) of 
inspiratory flow, improved maximal inspiratory pressure. These results indicated a 
significant training effect on the diaphragm and its ability to decrease intrathoracic 
pressure. Inbar et al. (2000) also found that while investigating twenty well conditioned 
athletes, the experimental group (n=lO) increased inspiratory muscle strength and 
endurance after a ten (10) week treatment program. 
Interestingly, a study conducted to determine the effectiveness of inspiratory muscle 
training on rowing performance revealed that along with a significant increase in 
inspiratory pressure, experimental protocol also improved the conductance of a sport 
specific exercise challenge (six minute rowing test) (Volianitis et al., 2001). These 
findings challenge the earlier statement by Sheel (2002) who questioned the 
transferability of respiratory training findings to performance. Again, the protocol used 
in this study resembled the methods used in a majority of these aforementioned studies. 
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Experimental subjects were trained for five (5) minutes (approximately 30 breathes) per 
day for eleven (11) weeks. At the conclusion of the investigation, subjects improved 
inspiratory measures and decreased perceived exertion due to training (Volianitis et al., 
2001). 
The comparison has been made that, "Respiratory muscles are skeletal muscle that are 
functionally similar to locomotor muscles. Their primary task is to act on the chest wall 
to move gas in and out of the lungs ... " (Powers & Howley, 2001, p. 189). This fact has 
led many researchers to train the respiratory muscles with some form of a resistive load. 
In doing so, they hope to elicit neurological and morphological adaptations to exercise. 
In reference to the overload principle, McArdle, Katch and Katch state that, "Exercising 
at a level of intensity higher than is normally performed can induce a variety of highly 
specific training adaptations that enable the body to function more efficiently." (1996). A 
concept attributed to DeLorme that expanded on the overload principle was that of the 
progressive resistance exercise principle, which proposed that movements against 
increased resistance over consecutive repetitions would show significant muscular 
strength improvements. Chatham extrapolates on this idea of incremental loading by 
suggesting that respiratory muscle training should introduce an appropriate resistance to 
the ventilatory musculature and occur three (3) times per week for an excess of four (4) 
weeks. Chatham (1999) further cites Smith et al. (1992), who suggest ''that if breathing 
pattern is controlled and substantial pressure generated during respiratory muscle 
training, appreciable increase in respiratory muscle strength and endurance may occur." 
(p. 2) 
38 
Several respiratory training devices are currently on the market (PowerBreathe®, 
TrainAir®, PowerLung®, UltraBreathe®, and Lung Exerciser®, PFlex®, Threshold® 
devices by TreatCOPD.com). The device chosen for this study is the Sports Breather® 
( donated by Dream Distribution, Inc.), a restrictive airway device that can control the 
amount of ambient air entering and exiting the device via the mouth. Graded levels of 
airway restriction can be manually changed on the device through the ventilation hub. 
lnspiratory grades 1-5 correspond with (-4, -5, -6, -13, -31 cm H20 while tested at 15 
liters/minute flow rate) pressures while expiratory resistances 1-4 coincide with ( +6 
cmH20 at 28 liters/ minute, + 14 cmH20 at 24 1/m, + 24 cm H20 at 20 1/m and +43 cmH20 
at 311/m) pressures (Fountain, C., 1997). 
Summary of Literature Review 
The elaborate organization of the pulmonary system is made of airways and lung tissue 
that serve as a vital transit area for the exchange between gases of the circulatory system 
and ambient air. The body's internal mechanism for regulating ventilation allows for a 
movement of air inside the body to accommodate specific oxygen needs. However, this 
intricate system can become compromised through a variety of structural and functional 
pathologies that can affect the timing,, efficiency and quality of inspiration and expiration. 
One such condition is that of asthma, a chronic obstructive disorder that affects many 
within the general population as evidenced by health census organizations and 
pharmaceutical distributors. This disease varies in severity, but is often characterized by 
episodes of coughing, wheezing, and a subjective feeling of a tight chest. Traditional 
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treatments have involved short-term, fast-acting bronchodilators as well as longer acting 
agents taken on as strict regiment. Although in most cases asthma is not a debilitating 
condition, it can disrupt the quality oflife many experience while conducting activities of 
daily living or when engaging in physical activity. 
Exercise-induced asthma is a variation of this more chronic obstructive disease that is 
classically defined by the bronchoconstriction brought upon by the water and heat lost 
due to excessive ventilation. Although common treatment modalities include fast-acting 
beta-2 agonists, it has been suggested that a way to attenuate the effects of this airway 
hyperresponsiveness could include the specific conditioning of the respiratory system, 
specifically the muscles of respiration. 
Resistive training of the respiratory muscles using resistive respiratory training devices 
has been experimentally used to treat the effectiveness of respiration in obstructive 
disorders such as asthma, COPD and cystic fibrosis with variable success. However, a 
significant portion of literature exists indicating the usefulness of this resistive muscle 
training to increase the healthy body's ability to draw ambient air into the lungs and just 
as effectively push it out. Unfortunately, no research exists regarding the use of 
respiratory training on exercise-induced asthma. This study will build upon the 
theoretical concepts and statistical findings of related lines of research to build a stable 
foundation for inquiry. 
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CHAPTER3 
METHODOLOGY 
This chapter will introduce the study design and specific methods and procedures used to 
research the effectiveness of resistive respiratory muscle training on exercise-induced 
asthma and pulmonary mechanics. 
Study Design 
A single-blind study using randomized control and experimental groups was conducted. 
Dependent variables or measures that did or did not change in response to the training 
were assessed at the beginning and end of the 5-week training period. The training 
period consisted of the five-(5) week period during which volunteer subjects used the 
resistive respiratory training device according to the study instructions. Pre-exercise 
stress testing was conducted prior to the five (5) week training period and represented the 
baseline values for each subject. Post-exercise stress testing values recorded both before 
and after training represented the response to acute exercise stress. Results of post-
exercise stress testing were expressed as a percentage of pre-exercise stress testing values 
to remain consistent with related scientific research (appendix 2-A). Dependent variables 
derived from spirometry were forced vital capacity (FVC), forced expiratory volume in 
one second (FEV-1 ), forced expiratory volume between 25-75% of exhalation (FEV 25-
75%) and peak expiratory flow (Pex). Dependent variables derived from oscillometry 
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were magnitude of respiratory impedance at five (5) hertz (Z5), total respiratory 
resistance at five (5) hertz (R5), proximal respiratory resistance at twenty (20) hertz 
(R20), distal capacitive reactance at five (5) hertz (X5). Modified Borg RPE scores were 
recorded during all exercise stress tests. 
Subjects 
Twenty-two (22) subjects originally volunteered to participate in the study's methods. 
During the course of baseline, pre-training testing, two (2) subjects became ill and opted 
out of the study, while eight (8) other potential volunteers did not choose to participate 
due to personal reasons unbeknownst to the investigation team. Follow-up telephone calls 
were not returned. Twelve (12) volunteer subjects (3 male/ 9 female) ranging in age 
(male 21.3±0.6 years; female 21.2±0.9 years), height (male 72.67±0.6 inches; female 
63.33±3.4 inches), weight (male 181.33±12.7 pounds; female 142±17.7 pounds), from 
Oklahoma State University- Stillwater served as the subject population. 
Group N 
Control 4 
Experimental 8 
Subjects were solicited through announcements in the Department of Athletics. 
Interested parties were directed to contact Matthew O'Brien, primary investigator for 
further information regarding the study. Upon contact, the primary investigator advised 
each individual about the purpose and requirements of the study and presented them with 
an informed consent form (appendix 1-A. All participating subjects were required to 
complete an "Asthma and Allergy" questionnaire to determine if they do in fact suffer 
from symptoms related to exercise-induced asthma. Subject approval required a cleared 
physical on file, a signed informed consent form and a questionnaire indicating an 
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unremarkable previous medial history and absence of any precluding factors to physical 
activity. 
Testing Facility 
The testing facility was located in the Seretean Wellness center at the Oklahoma State 
University- Stillwater campus. The room used was cleared of visible allergens (dust, 
plant-life, etc.) and was maintained at a temperature of (22-24° C degrees). The facility 
housed a Jaeger-Toennies Impulse Oscillometry Measuring Station, capable of collecting 
spirometric measurements and impulse oscillometric determinations of airway resistance 
and reactance. A Quinton Q50 treadmill capable of0.6-6.0 mph (0.96-9.6 km/h) belt 
speed, a digital stop watch, and a telephone were placed in the laboratory room. Polar® 
heart monitors were used to monitor subject heart rate during exercise. Individual 
subjects were instructed to bring any prescribed (by their own physician) fast-acting 
bronchodilating agents with them to all appointments. The primary investigator had 
access to a CPR mask and bag valve mask during the course of testing. 
Heart Rate Monitors 
Polar® heart monitors were fastened around the subject's chest area and the heart rate 
watch was held by the primary investigator so that the subjects' heart rate was accurately 
monitored. This device assured investigators when the subject has attained 85% maximal 
heart rate. 
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Jaeger-Toennies Impulse Oscillometry Measuring Station® 
This device utilizes a non-invasive procedure to determine pulmonary obstruction and 
location of repiratory impedance. Specifically, this study will target the amount of 
respiratory obstruction of the lower-level bronchioles and terminal branches leading into 
the alveolar sacs. This station is composed of a mainframe computer linked with a 
pnuemotach, "Y" frame lead, and a face attachment for measurements. Signals are 
generated at the pnuemotach and "superimposed on the respiratory tidal breathing 
waveform of the patient in the Y-adapter while the patient simply inhales ambient air via 
mouthpiece, pneumotach and terminating resistance(< 0.1 kPa/1/s)" (Jaeger-Toennies®). 
Signals are then monitored at the MasterScreen IOS® station differentiating respiratory 
impedance at specific pulmonary locales. 
Preliminary Procedures 
Each subject was informed by the informed consent form and the primary investigator as 
to what their participation entailed. They were informed of any potential benefits and 
risks due to participation. Participation involved two separate testing appointments and 
an intervening five-(5) week training period. At the conclusion of the study, all 
volunteers were given the option of keeping the respiratory training device. Potential 
risks of the study did not exceed the same level of risk incurred through participation in 
physical activity, namely running. After signing a letter of informed consent (appendixl-
aa) indicating their understanding of the study purpose and requirements, subjects 
completed a subjective history assessment targeting respiratory dysfunction after exercise 
(appendix 1- bb). Five (5) days were scheduled at both the beginning and end of the five-
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(5) week training period to collect preliminary and post-training data. Subjects were 
assigned one hour appointment times on any one of the five potential testing days. When 
scheduling the post-training appointment, subjects typically returned on the same day of 
the week so that all experienced the full five (5) weeks of training with the resistive 
respiratory training device. Subjects were instructed on the informed consent form to 
not take any short-acting prescription drugs treating their symptoms of exercise induced 
asthma or complete any vigorous exercise on the day of testing. No other long acting 
drug therapy was interrupted. They were required to bring any fast-acting aerosol 
bronchodilators that had been prescribed to them for EIA symptoms for safety. Subjects 
were instructed to wear standard exercise clothing (shorts and t-shirts) including a pair of 
athletic shoes equipped for running. The primary investigator, trained in cardio-
pulmonary resuscitation for the professional rescuer, was present at all times during 
diagnostic assessment. 
Grouping 
Subject names and identification numbers were entered into a statistical package software 
program (Statistical Package for the Social Sciences, Chicago, IL.) where two lists were 
randomly generated using the random generator program. These lists were then coded as 
experimental (1) and control (0) group subjects. All names and records of subject 
participation were kept completely confidential and secured in the primary investigators 
locked office. At the conclusion of the study, this information was destroyed or deleted. 
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Emergency Action Procedures 
The primary investigator trained in advanced CPR and life saving techniques was present 
at all times with a CPR and a bag valve mask able to intervene at any point during the 
testing protocol. The medical supervisor, a licensed physician, was on campus within 
one half mile (0.5 mile) of the testing facility located at the Oklahoma State University 
Health Services Building and was able to intervene upon contact. Emergency Medical 
Services was also noted as the secondary contact in case of emergency. 
If at any point during this exercise testing, the athlete experienced strong presentation of 
symptoms such as angina, light-headedness, sudden pallor, or cyanosis (Hansen, 1982), 
the testing run would have been ceased and a bronchodilator prescribed to that individual 
would have been self-administered. If at any point of the exercise testing, the athlete lost 
consciousness, immediate first aid and CPR procedures would have been initiated 
including contacting emergency medical services and the study's medical supervisor. 
Procedures 
Individual subjects reported at their assigned testing times to the Seretean Wellness 
Center where height and weight was measured. Resting heart rate through palpation of 
the radial pulse was also measured while the individual was seated in a standard chair. 
Spirometric and forced oscillation measurements using the Impulse Oscillometry 
Measuring Station® (IOS, Jaeger-Toennies) was taken while the subject was seated in a 
standard chair allowing ninety degrees (90°) of knee and hip flexion. The subject was 
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seated so that their cervical spine was slightly extended to prevent premature glottic 
closure. The primary investigator adjusted the extension arm of the IOS measuring 
station so that the oral measuring device was proximal to the subject's head. The subject 
was then instructed to breathe normally into the mouth piece for approximately thirty 
(30) seconds until three valid measurements were recorded. An average for each measure 
was calculated. The preliminary measures included forced expiratory volume in one 
second (FEV-1 ), forced expiratory volume between 25-75% of exhalation (FEV 25-75%), 
forced vital capacity (FVC), peak expiratory flow (Pex), magnitude of respiratory 
impedance (Z5), total respiratory resistance (R5), proximal respiratory resistance (R20) 
and distal capacitive reactance (X5) using the IOS station. These values served as a 
baseline, pre-exercise stress testing measure catalog. 
A calculation of work rate of the individual subjects at eighty-five percent (85%) of the 
maximal heart rate (American Thoracic Society, 1994) was then calculated. The subjects 
age was subtracted from two hundred and twenty (220) and multiplied by 0.85 (85%) to 
obtain predicted maximal heart rate. The treadmill belt speed was advanced so that the 
subject would reach this maximal heart rate while causing no cardiovascular 
complications. 
Before the initial exercise-stress test began, the investigator explained the use of the 
modified Borg scale of perceived exertion or breathlessness (appendix 1-C). The subject 
assumed the treadmill placing both hands on the supportive railings with both feet to each 
side of the treadmill belt. The investigator began the treadmill at a moderate speed (2 
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miles/ hour) and instructed the subject to engage walking on the treadmill belt. The 
investigator then gradually increased the treadmill speed by increments of 1 (one) mile 
per hour. Once the speed of the treadmill belt had increased the heart rate to the 
predicted percentage of maximal values, the subject continued at this pace for 7 (seven) 
consecutive minutes (Hallstrand, 2002, ASCM, 2000, ATS, 1994). The investigator 
asked the subject to rate their perceived level of exertion or breathlessness at minute 2, 3, 
4, 5, 6, and 7 of the total exercise stress test. At the end of the seven-minute period 
(85% of maximal heart rate) exercise, the investigator gradually decreased the treadmill 
speed to a rate of one (1) mph and the challenge was concluded. The subject then 
dismounted the treadmill and all respiratory post-exercise stress testing measures 
(excluding height and weight) were assessed in same manner as the pre- exercise stress 
testing measures. 
Spirometry including FVC, FEV-1, FEV 25-75% and Pex were measured immediately after 
exercise challenge and at 5-, 15- and 30-minute intervals for the proceeding 30 minutes 
(K.uk:atka DS, et al., 1998, Hansen, J.E., 1982). A total of four (4) spirometric measures 
were recorded. The maximum deviation of the four measures was selected indicating the 
most dramatic response to the exercise stimulus. This investigation focused on response 
to a stimulus and intervention and therefore only the maximal responses to exercise-stress 
testing were included in the data pool. If at any time, subjects FEV-1 dropped below 
25% of their predicted, measurements would be ceased and bronchodilators would be self 
administered. No data was deleted from the study for this reason. 
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Impulse oscillometry measures including magnitude of respiratory impedance (Z5), total 
respiratory resistance (R5), proximal respiratory resistance (R20) and distal capacitive 
reactance (X5) were recorded within the intervening time between spirometric scores. 
Measures were recorded at the 4 (four)- and 20 (twenty)-minute markers to prevent 
confounding measures due to increased lung volume caused by forced maneuver 
spirometric measurements. 
Training method 
All subjects were naive to respiratory muscle training. At the conclusion of their exercise 
stress test on day one, each individual was given a SportsBreather® respiratory training 
device and verbally instructed on the proper use of the instrument. Experimental group 
subjects received a complete, manufactured Sports Breather® device whereas the control 
group received a Sports Breather® which had the internal bladder removed (a placebo 
device). These modified devices represented a form of placebo training. Written 
instructions (appendix 1-D) were also given to each subject so that proper use and 
standard protocol were assured throughout the training period. 
Initial instructions (appendix 1-D) for both groups included placing the lips around the 
mouthpiece without clenching their teeth. While both resistance settings are set to one 
(I) or minimal resistance, the subject began by inhaling deeply for three to four (3-4) 
seconds, pausing for one to two (1-2) seconds and then slowly exhaling for 
approximately five (5) seconds. The subject would then engage in resistive respiratory 
training at level I (one) (inspiratory and expiratory) for the first week. At the beginning 
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of the second week, the athlete would then increase both resistance levels to two and 
engage in training protocols for the full week. This mode of increasing resistance 
settings continued for all five ( 5) weeks. Due to the independent resistance settings, the 
inhale resistance setting on the hub was set to 4 (four) (maximum allowed) for weeks 
four ( 4) and five ( 5). If at any time during the training with the resistive respiratory 
device, the subject felt faint, tightness in the chest or excessively tired, they were 
instructed to discontinue training for that day and inform the primary investigator 
immediately. 
Subjects performed breathing techniques according to a modified technique #1 suggested 
by the manufacturer (SportsBreather®) and defined above. The subject engaged in 
training by forcefully breathing into the device using the above technique for thirty (30) 
breathes or approximately six ( 6) breathes per minute for an approximate training time of 
five (5) minutes. This protocol was conducted two (2) times per day and repeated every 
day of a calendar week for five ( 5) weeks. 
The primary investigator performed periodic assessment of protocol adherence in the 
form of telephone or personal communication on the Friday of each week. Any technical 
or problems with the respiratory muscle training device were resolved at these times 
unless study reliability was threatened. In cases of device malfunction, a new one was 
issued to the individual. Only one additional device was given to a subject who had lost 
their original one. 
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STATISTICAL PROCEDURES 
Subject data was compiled and analyzed using the Statistical Package for the Social 
Sciences (SPSS®, Chicago, IL).· Pre-training randomization was checked using student's 
t-tests on all dependent variables (appendix 2-B). 
The effect of training with the resistive respiratory device was determined using a two-
way repeated-measures analysis of variance (ANOVA) using subject identification 
numbers (social security numbers) as a repeating variable, group (experimental/ control) 
and training status (pre and post-training) as the independent variables. The following 
groups of respiratory measurements were statistically analyzed; (hypothesis 1) 
experimental versus control groups' pre-exercise stress testing FVC, FEVl, FEVl/FVC, 
PEF and FEV 25/75 prior to and following a five (5) week training period; (hypothesis 2) 
experimental versus control groups' post-exercise stress testing FVC, FEVl, FEVl/FVC, 
PEF and FEV 25/75 prior to and following a five (5) week training period; (hypothesis 3) 
data relating to perception of dyspnea as represented using the modified Borg scale of 
RPE (breathlessness) was plotted using a 2 X 7 X 2 repeated measures analysis of 
variance feature to graph the means of each minute of the exercise stress test for both 
groups (appendix 2-E) and was analyzed using group means for each minute of the seven 
(7) minute exercise stress test before and after training; average change in RPE for each 
group was also analyzed using group and average difference between pre-and post-
training (2 X 2); (hypothesis 4) experimental versus control groups' post-exercise stress 
testing magnitude of respiratory impedance (Z5), total respiratory resistance (R5), 
proximal respiratory resistance (R20) and distal capacitive reactance (X5) prior to and 
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following a five (5) week training period. In addition, the effect of resistive respiratory 
training on spirometry was assessed in the experimental group using paired Mests of their 
pre- and post-training values. 
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CHAPTER4 
RESULTS 
Issues regarding data collection included review of individual subject spirometric values 
indicating a recording malfunction producing data that was obviously misrepresentative 
of actual physiology. After each forced expiratory maneuver was conducted, data was 
analyzed by the IOS software relative to body size and baseline measures and saved to 
subjects file. However, on random occasion the Master IOS station software would 
errantly analyze data according to a standard unknown to this investigation team and 
store data. Attempts to contact the device manwacturer and correct software malfunction 
proved unsuccessful therefore, all data were included due to inability to find and correct 
individual subject data. After review of the maximal values of all the associated factors 
included for statistical analysis, none of the measurement anomalies were included. 
Additionally, following the five (5) week training session, all individuals reported having 
upper respiratory symptoms such as nasal drainage, sinus blockage or other related 
symptoms possibly increasing oscillometric measures recorded. 
Physical data for group (mean± standard deviation) are shown in table 4-1: 
Table 4-1 
Sex N Age (mean±SD) Height (inches) (mean±SD) Weight (lb) (mean±SD) 
Male 3 21.3±0.58 72.67±0.57 181.33±12.66 
Female 9 21.2±0.87 63.33±3.39 142±17.70 
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Analysis of baseline spirometry and oscillometry in table 4-2 revealed no statistical 
difference between groups on pulmonary mechanics measures except for FVC (p=.046) 
indicating that although there was a statistical difference between the experimental group 
(5.347± 1.29 L) and control group (4.115 ± .63 L), randomization of subjects was 
essentially accomplished (appendix 2-B). 
T bl 4 2 B li G a e 
-
. ase ne . roup St ti f a SICS 
(;ontrol Experimental 
N Mean Std. Deviation N Mean Std. Deviation 
Z 5HZ 4 14.3375 ~.69092 8 3.9125 1.55073 
R 5HZ 4 14.1000 ~.42866 8 3.7038 1.52748 
R 20HZ 4 ~.4250 1.55886 8 3.1675 1.02112 
X 5HZ 4 1.3700 1.23925 8 1.2175 .45663 
FVC 4 ~.3475 1.29611 8 4.1150 .62753 
FEV 1 4 14.2350 1.29536 8 3.3363 .80631 
FEVlFVC 4 r78.0200 rl.82847 8 80.4638 11.09776 
PEF 4 8.0175 14.16044 8 6.1113 2.43383 
FEF2575 4 ~.7700 1.43520 8 3.4763 1.63067 
Hypothesis 1 
Review of subject data in table 4-3 showed no effect of resistive respiratory training on 
pre-exercise stress testing spirometry (appendix 2-C). Five two-way ANOVA analyses 
yielded FVC (p=.890), FEVl (p= .994), FEVl percentage ofFVC (p= .788), PEF (p= 
.281) and FEY 25/75 (p= .820). 
Table 4-3 
ean±SD 
re-training FVC 
.1150±.62753 
. 7050±2.5 5771 
3.5788±1.48289 
ean±SD 
.2350±1.29536 
.8537±1.36352 
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GROUP Mean±SD 
Pre-training FEVl/FVC Control 78.0200±7.82847 
Exp 80.4638±11.09776 
Post-training FEVl/FVC Control 78.5325±5.71843 
Exp 78.3750±12.41913 
GROUP Mean±SD 
Pre-training PEF Control 8.0175±4.16044 
Exp 6.1113±2.43383 
!Post-training PEF Control 5.6175±2.78585 
Exp 5.4863±2.75380 
GROUP Mean±SD 
!Pre-training FEF2575 Control 3. 7700±1.43520 
Exp 3.4763±1.63067 
!Post-training FEF2575 Control 3.4675±2.11262 
Exp 2.9150±1.88667 
Hypothesis 2 
There was no effect of resistive respiratory training on post-exercise stress testing 
(appendix 2-D). The hypothesis data in table 4-4 did not reach statistical significance for 
FVC (p=.858), FEVI (p= .770), percentage ofFEVl/ FVC (p= .083), PEF (p= .912) and 
FEV 25/75 (p= .497). 
Table 4-4 
GROUP Mean±SD 
Pre-training FVC Response Control 101.12±3.66 
Exp 102.10±6.07 
Post-training FVC Response Control 155.37±104.94 
Exp 145.91±88.33 
GROUP IMean±SD 
Pre-training FEV 1 Response Control 105.18±15.70 
Exp 97.48±14.42 
Post-training FEV 1 Response Control 150.59±101.84 
Exp 162.80±113.37 
GROUP IMean±SD 
Pre-training FEVl/FVC Response Control 105.10±11.32 
Exp 97.23±13.29 
Post-training FEVl/FVC Response Control 98.50±3.18 
Exp 108.72±11.93 
GROUP Mean±SD 
Pre-training PEF Response Control 111.41±49 .43 
Exp 104.36±28. 79 
Post-training PEF Response Control 167 .57±92.90 
Exp 153.57±105.41 
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ean ±SD 
re-trainin FEF2575 
ost-trainin FEF2575 
16.70±216.26 
Hypothesis 3 
Graph 4-5 shows the control and experimental groups reported mean RPEs in relation to 
breathing or dyspnea both before and following the five (5) week training session. There 
was a significant interaction between time and group (p=.011) indicating that the 
experimental and control group values were different at any given time point. The 
interaction of interest between group, training and time did not reach significance 
(p=.091). Other main effects for RPE (breathlessness) include: RPE (p=.161) and time 
(p=.000). Analysis for the remaining interaction revealed for RPE and group (p= .364) 
(Appendix 2-E). 
Graph 4-5 
RPE During Exercise Challenge 
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Change in RPE 
The change in RPE (~ RPE) scores found in figure 4-6 were calculated by subtracting the 
post-training means following the five (5)- week resistive respiratory training session 
from the pre-training means of both groups at each time point: 
post-training mean - pre-training mean= change in RP E 
The resultant values for both groups are shown in the graph below. The ~ RPE for the 
two groups following the five (5)-week resistive respiratory training session begins to 
deviate after minute one (1) where the experimental group~ RPE was 1.38 at minute two 
(2) of the exercise stress test and gradually increased to a ~ RPE of 2 at minute seven (7). 
The control group ~ RPE exhibited an opposite trend moving from a 1.42 at minute one 
(1) to a .53 at minute seven (7). However, the differences in~ RPE between 
experimental and control was not statistically different. Post-treatment differences 
between the interaction of group and RPE were (p= .091) (appendix 2-F). 
Figure 4-6 
Change in RPE Post-Treatment 
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Other information that was collected, but unplanned for during the study included 
subjective data relating to RPE scores. Subjects enlisted in the experimental group did 
report to the primary investigator on the second exercise-stress testing session following 
the five (5) week training session such responses as it was "easier to breath during and 
after running", "My chest was not as tight when I was done running ... " and other similar 
anecdotal evidence. 
Hypothesis 4 
There was no significant difference detected among post-exercise stress testing impulse 
oscillometry values found in table 4-7. Analyses included respiratory impedance 
measured at 5Hz (p=.186), total respiratory resistance at 5Hz (p=.105) and at 20Hz 
(p=.916) as well as distal capacitive reactance at 5 hertz (p=.485) for both groups 
(appendix 2-G). Table 4-7 
ean±SD 
107.79±14.92 
115.03±18.99 
133.96±34.14 
113.63±15.17 
109.28±14.30 
123.01±21.40 
168.18±90.68 
116.88±15.41 
ost-training Rat 20Hz Response 
106.77±34.84 
143.88±98.71 
104.70±23.23 
105 .38± 18.33 
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HYPOTHESIS 5 
The tables in appendix 2-H show the percent change in post-exercise stress testing 
measures from pre-exercise stress testing of the experimental groups spirometry scores 
prior to (baseline) and following a five (5) week training period (response). Independent 
sample t-tests were run analyzing the experimental groups' post-exercise stress testing to 
training and found no significant increase along each of the following parameters, FVC, 
FEVl, FEVl/FVC, PEF, and FEV 25/75. Analyses for FVC (t = -1.394; p=.206), 
FEVl (t= -1.588; p=.156), FEVI/FVC (t= -1.948; p=.092), PEF (t= -1.203; p=.268) and 
FEV25/27 (t=-1.159; p=.173). 
DISCUSSION OF RESULTS 
A majority of the hypotheses tested were not supported by statistical evidence. Many 
factors contributing to this lack of remarkable findings will be explored in the following 
narrative. First and foremost, solicitation and retention of the subject population created 
the most critical pitfalls of the study's methods. The subject population drastically 
decreased since the initial invitation into the study from twenty-one potential subjects 
down to twelve volunteer subjects (eight in the experimental and four in the control). As 
the subject population decreased so did power of the study statistics. 
Additionally, review of the FEV-1 values during post-exercise stress testing for each 
individual also created a concern regarding the target population used during this study. 
A fifteen (15%) percent decrease in pre-exercise FEVl following exercise is the standard 
diagnostic criterion for EIA. Only one subject actually exhibited this decrease of their 
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resting FEVl following the seven (7) minute sub-maximal run on the treadmill. This 
finding raises an interesting question as to how many individuals are misdiagnosed with 
exercise-induced asthma according to self-reported symptoms. Similar studies 
investigating the relationship between self-reported symptoms and confirmed exercise-
induced asthma and bronchoconstriction also have found a disparity between the number 
of self-reported cases and confirmed through laboratory testing (Capao-Filipe, et al, 2003, 
Rice, S., et al, 1985, Rundell, K.W., et al, 2001, Rundell, K.W., et al, 2000, Holzer, K., 
Anderson, S.D., and Douglas, J., 2002), though not of the magnitude in our study 
population. The subjects enlisted in this study had all been diagnosed through symptoms 
associated with EIA and no prior clinical tests had been conducted to determine any 
spirometric deficiencies in forced expiratory volume. Subsequently, all of the subjects 
had been prescribed some form of a fast-acting bronchodilator to treat the reported 
symptoms. However, post-exercise spirometric data in this study was not indicative of 
treatment prescribed by a physician as all short-term bronchodilating medication was 
prohibited on the day of testing. 
Rundell and Spiering (2003) found that when studying the transient condition of exercise-
induced bronchospasm in a large population (370) of Olympic caliber athletes, several of 
the athletes (9 of the 111 total diagnosed with EIB) actually exhibited a less severe 
condition called inspiratory stridor. The authors found that most athletes are diagnosed 
through self reported symptomology as was done within the present study. Koester and 
Amundenson (2002) also raised an interesting condition called paradoxical vocal-cord 
dysfunction (PVCD) that is often confused with exercise-induced asthma and could be a 
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possible explanation for the subject population's pulmonary function tests. The authors 
report that although pulmonary function tests conducted pre- and post-exercise may be 
normal, those who suffer from PVCD suffer from a transient closing of the vocal cords 
causing asthma-like symptoms during exercise. The study's investigation team suggested 
that any exercise-limiting pathology such as EIB should be diagnosed through 
spirometric measuring means, thus preventing the misdiagnosis ofEIB. None of the 
volunteer subjects in this study were tested for or reported having been previously 
diagnosed with inspiratory stridor or PVCD. Based on our inability to confirm EIA in all 
but one study participant, our data are more correctly interpreted as the effects of 
respiratory training on normal, trained subjects. 
The hypotheses investigating the values of pulmonary mechanics measured through 
spirometry following an exercise stress test collectively revealed no statistically 
significant findings, although FEVl/FVC did show a potential trend (p<0.01) toward 
hypothesis confirmation. Additionally, post-exercise stress testing measures of the 
experimental group using the intact resistive respiratory training device compared to the 
control group showed an interesting trend whereby the means of the experimental group 
for all spirometry tests increased while the control group means decreased. 
These findings support the previous work done by Chatham, et al. (1999) and Volianitis, 
et al. (2001) who established minor increases in expiratory measures and performance in 
healthy subjects after a specified training period and regimen. In these studies, however, 
larger sample populations (N> 12), longer training periods (>5 weeks) and more intense 
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training programs (>30 breathes, 2 times I day) were used, possibly leading to statistically 
significant results. It is possible that the five (5)-week training period, training protocol 
and small sample population used in the present study decreased the power to identify 
such a potential small difference. Sheel (2002) further explains that in many respiratory 
training studies such as this, small population size typically impact the significance of the 
results. 
The use of an appropriate testing modality and intensity also could have provided for a 
more powerful look into the potential differences between the training groups. If these 
individuals were trained, would a treadmill producing a speed fast enough for each 
subject to reach eighty-five percent (85%) of their maximal heart rate during a seven-
minute exercise-stress test be intense enough to truly elicit an EIA response? Although 
these are the typical conditions used in many diagnostic protocols (ATS, ACSM), Storms 
(1999) reports that most symptoms ofEIA could take as long as fifteen to thirty minutes 
following the start of exercise to present in the well-conditioned athlete with a testing 
intensity ofup to ninety-five percent (95%) of maximal heart rate. However, the ATS 
(2001) does stipulate that during these stress tests, it is not necessary to observe actual 
signs ofEIA as respiratory mechanics such as a decrease ofFEVl are usually detected by 
spirometry. 
Subjects in the current study were trained through both inspiratory and expiratory muscle 
training and then measured through forced expiratory maneuvers. Increased means for 
spirometric measures involving muscular strength and power (peak expiratory flow, 
62 
FEVl, FEVl/FVC) in the experimental group could be explained by adaptive changes in 
the respiratory muscles through training against an increased resistance. Studies (Lisboa, 
et al, 1994, 1997, Weiner, et al, 2000, 2002, Inbar, et al, 2000) focusing primarily on 
inspiratory muscle training for clinical populations reported significant increases in 
inspiratory muscle strength measured by peak inspiratory force and its' component of 
speed of inspiration. These studies, however, investigated more subjects per training 
group and trained individuals for longer periods of time potentially creating a 
distinguishable difference between groups. 
The spirometric data obtained in this present study also could be a result of true 
physiological response to resistive respiratory training. By not reaching significance, this 
investigation could support the work of Amonette and Dupler (2001) and Boutellier et al 
(1992) who found no significant changes in FVC and FEVl between conditioned athletes 
randomly separated into a control and experimental group conducting inspiratory and 
expiratory training. Hanel and Sechler (1991) also found no significant change in FEVl, 
FVC, FEVl/FVC and Pex. These studies were similar in population and methods 
thereby raising the question as to whether resistive respiratory training does, in fact, 
positively affect spirometry of trained individuals or are the testing and training methods 
too different. Amonette and Dupler (2001) believed that while training on a resistive 
device, the lungs adapt to the specified resistance and when testing spirometry there is no 
similar resistance, thereby producing invalid values of spirometry. 
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The investigation team concedes that the data in this study could be interpreted as a valid 
indication ofrespiratory muscle physiology after training for five (5) weeks, however, 
when viewed relative to previous literature, one must realize the potential for variability 
due to methods and population. 
To our knowledge, this study is the first to investigate resistive respiratory training and its 
effect on airway resistance through impulse oscillometry. We found no significant 
change between groups both pre- and post-training, indicating that respiratory airways 
reacted similarly thought the course of the study regardless of the group training status. 
Subjects within the experimental group exhibited a consistent albeit insignificant, 
decrease in all measures of pulmonary resistance when compared to the control group 
subjects. Interestingly, the second testing session following the five (5) week training 
period occurred in early April, a spring month in Oklahoma. The spring season also 
brought air-home allergens aggravating seasonal allergies that commonly affect 
asthmatics and in this case, all subjects of this study. Logic would indicate that an 
increase in the amount of airborne allergens would increase pulmonary resistance 
measures in both groups equally, however, that was not the case in the experimental 
group. The control group, on the contrary, saw an increase in all pulmonary resistance 
measures following the exercise stress test. The experimental groups' chronic use of the 
resistive respiratory training device possibly cleared and maintained the pulmonary 
airways even during times of bronchoconstriction. 
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A significant problem highlighted throughout the data collection is the recording 
anomalies found while testing several of the volunteer subjects. The Master IOS station 
software was calibrated prior to each day of testing, however, the equilibration software 
seemed to misread subject data and therefore report measurement aberrations that were 
clearly non-physiological in nature. Due to the sensitive and timely nature of each 
measure collection, forced spirometric maneuvers were only conducted once more if a 
recording mistake was observed initially. 
The rationale for this decision was based primarily in the theory that once the elastic 
properties of the smooth muscle airways and parenchymal fibers in the lung were 
stretched from their original "resting" position, any subsequent tidal breathing and forced 
maneuvers would be registering the newly "stretched" range (Scichilone, et al, 2000, 
Scichilone, Permutt & Togias, 2001, Skloot, G., Permutt, S., Togias, A. 1995). This 
phenomenon would result in a false indication of tissue resistance, compliance and the 
severity of the underlying pulmonary pathology. 
The perception of breathlessness by the experimental group subjects as opposed to the 
control group did not reach statistical significance (p=0.091), however, upon a closer 
review of the reported RPE through the post-training exercise stress test, the subjects 
within the experimental group reported less of a deviation from the RPE scores of the 
pre-training exercise stress test. This subjective phenomenon could again be explained by 
the resistive respiratory training's ability to decrease the sense of breathing exertion. As 
experimental group members became increasingly trained to forcefully breathe against an 
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artificial resistance, respiratory musculature developed a more efficient ability to move 
air in and out of the airways during episodes of perceived bronchoconstriction. These 
trained individuals would decrease the overall effort used to breath during and after 
exercise, thereby decreasing their sense of exertion and breathlessness. 
This effect is best seen in figure 4-6, which shows a growing disparity between the 
experimental and control groups. As shown on the chart, the experimental group average 
progression of change in RPE from pre-training to post-training consistently increased 
throughout the seven (7) minute exercise stress test whereas the control group posted a 
smaller rate of change. Statistical analysis between both groups average change in RPE 
over time showed p< 0.1 (p=0.091 ), a trend towards hypothesis confirmation that should 
be noted, particularly with the low statistical power of our study. 
Our data coincided with other research (Wiener, et al, 2000, 2002, Suzuki, et al, 
Volianitis, et al, 2000) showing that resistive respiratory training could possibly attenuate 
the sensation of dyspnea involved with strenuous exercise. If drawing and expiring a 
breath against an increased resistance develops neural adaptations providing for more 
efficient movement of air, we agree with other research that less energy expended and 
less fatigue induced through strenuous exercise will yield a decreased sense of exertion 
and breathlessness. 
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CHAPTERS 
CONCLUSIONS 
Upon review of the data represented in the previous chapter, it is evident that the study 
methods were severely impacted by the small subject population. Subsequently, 
definitive statements regarding each hypothesis are difficult to pose and support in light 
of the small subject population and equipment recording reliability. The reader must 
consider these points when evaluating the data and associated conclusions. 
Although none of the research hypotheses reached statistical significance there are 
several areas of interest raised when evaluating the data for the experimental groups' 
pulmonary mechanics scores. 
When reviewing the data of the experimental group's post-exercise stress testing 
measures, there did seem to be a slight increase in all relevant forced expiratory 
maneuvers. This phenomenon could be due to an actual training effect as hypothesized 
or due to erroneous results. The increase could potentially be due to an increase in 
expiratory muscle strength brought upon by breathing into the resistive respiratory 
training device on a progressive five (5)-week cycle. 
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Oscillometry data showed that although no significant changes were recorded pre- and 
post-training, resistive respiratory training did not increase nor decrease respiratory 
resistance after a five ( 5) week training period. 
Perception of exertion or breathlessness could potentially be improved through resistive 
respiratory training over a five (5) week period. Our data are consistent with other 
research that training with some resistance has a greater effect on perception of exertion 
and breathlessness than training without. 
RECOMMENDATIONS 
It is clear that future research investigating this area of resistive respiratory training for 
the treatment of athletes diagnosed with exercise-induced asthma should correct the 
methodological problems experienced within this study. Increasing volunteer subject 
population would prevent many of the problems of statistical analysis and the subsequent 
ability to generalize to the greater population allowing the proper interpretation of future 
research data. Many of the intriguing albeit insignificant findings of the present data 
could be further investigated. 
Maintaining reliable diagnostic pulmonary equipment capable of recording a time series 
of measures would prevent data collection aberrations and contribute to the data validity. 
Although the device used in this study was calibrated daily and maintained acceptable 
measure validity, the progressively scheduled manner in which data samples were 
collected created much of the measurement error observed. By following the study's data 
collection methods and maintaining the timed structure of the data collection, it was 
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difficult not to contribute to the measurement error. Communication with device 
manufacturers did not correct the collection problems. Future research should seek and 
certify that the data collection equipment used will have the ability to accurately collect 
series of samples without re-calibrating the unit in between samples. 
Future research should concentrate on the differentiation of exercise-induced asthma and 
exercise-induced bronchospasm to elucidate the actual underlying pathology and stimuli 
of each. The realization that only one of twelve of the subjects tested actually suffered 
from EIA is disconcerting and highlights the problem of identifying a truly affected 
population. Targeting inflammatory markers of a true asthmatic condition such as an 
elevated white blood cell count and increased release of histamine versus a temporary 
narrowing of the smooth muscle airways without any associated inflammation seen with 
EIB would improve population identification (Hermansen, 2004). The ability to 
differentially diagnose exercise-triggered asthma from transient EIB through clinical 
testing would allow future research to develop more accurate hypotheses and subsequent 
conclusions based on pathology. 
Along with a decreased sense of exertion evidenced by decreased RPE scores, an area of 
interest that developed throughout the study was that of pharmacological treatment 
patterns. Although no actual record of fast-acting bronchodilators was kept throughout 
the study, many individuals in the experimental group reported using their prescription 
medication for EIA less if not at all. Interestingly, there were no such reports from those 
subjects within the placebo control group. Further research should include this variable 
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in the methods to lend further support to the notion that resistive respiratory training can 
serve as training aid in general. 
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Oklahoma State University 
Institutional Review Board 
Protocol Expires: 1/14/2005 
Date: Thursday, January 15, 2004 IRB Application No ED0468 
Proposal Title: Resistive Respiratory Training and it Effects on Pulmonary Mechanics in Individuals 
Diagnosed with Exercise Induced Asthma 
Principal 
lnvestigator(s): 
Matthew "((.Brien 
418 Willard 
Stillwater, OK 74078 
Reviewed and 
Processed as: Full Board 
Michael Davis 
264 McElroy Hall 
Stillwater, OK 74078 
Approval Status Recommended by Reviewer(s): Approved 
Dear Pl: 
Your IRB application referenced above has been approved for one calendar year. Please make note of 
the expiration date indicated above. It is the judgment of the reviewers that the rights and welfare of 
individuals who may be asked to participate in this study will be respected, and that the research will be 
conducted in a manner consistent with the IRB requirements as outlined in section 45 CFR 46. 
As Principal Investigator, it is your responsibility to do the following: 
1. Conduct this study exactly as it has been approved. Any modifications to the research protocol 
must be submitted with the appropriate signatures for IRB approval. 
2. Submit a request for continuation if the study extends beyond the approval period of one calendar 
year. This continuation must receive IRB review and approval before the research can continue. 
3. Report any adverse events to the IRB Chair promptly. Adverse events are those which are 
unanticipated and impact the subjects during the course of this research; and 
4. Notify the IRB office in writing when your research project is complete. 
Please note that approved projects are subject to monitoring by the IRB. If you have questions about the 
IRB procedures or need any assistance from the Board, please contact me in 415 Whitehurst (phone: 
405-744-5700, colson@okstate.edu). 
Carol Olson, Chair 
Institutional Review Board ' 
Appendix 1-bb 
Institutional Review Board Application IRB# E0468 Adjoiner 
81 
Date : Thursday, April 22, 2004 
Oklahoma State University 
Institutional Review Board 
Protocol Expires: 1/14/2005 
IRB Application No ED0468 
Proposal Title: Resistive Respiratory Training and it Effects on Pulmonary Mechanics in Individuals 
Diagnosed with Exercise Induced Asthma 
Principal 
lnvestigator(s): 
Matthew O'Brien 
418Willard 
Stillwater, OK 74078 
Reviewed and 
Processed as: Full Board 
Michael Davis 
264 McElroy Hall 
Stillwater, OK 74078 
Approval Status Recommended by Reviewer(s) : Approved Modification 
Please note that the protocol expires on the following date which is one year from the date of the approval of the original 
protocol: 
Protocol Exphs: 1/1412005 
Carol Olson, Director of University Research Compliance 
Thursday,April22,2004 
Date 
Approvals are valid for one calendar year, after which time a request for continuation must be submitted. Any modifications 
to the research project approved by the IRB must be submitted for approval with the advisor's signature. The IRB office 
MUST be notified in writing when a project is complete. Approved projects are subject to monitoring by the IRB. Expedited 
and exempt projects may be reviewed by the full Institutional Review Board. 
OKLAHOMA STATE UNIVERSITY RESEARCH 
Resistive respiratory training and its effects on the pulmonary mechanics within individuals 
diagnosed with exercise induced asthma 
IRB#E0468 
Investigation Procedure Explanation 
According to the original IRB approved methodology, two groups of subjects were used to ensure 
a true experimental design consisting of a control and experimental group. Upon initial testing of 
pulmonary function prior to the five (5) week training period, subjects were randomly assigned 
into an experimental group and issued an intact resistive training device while the control group 
received the modified device offering a uniform minimal resistance throughout the same training 
period. This approved methodology was formulated so that the potential for measuring a 
treatment effect could be established. At the conclusion of the training period all subjects' 
pulmonary function were tested again and subjects within the control group were debriefed 
regarding their participation within the study. These subjects were informed of the modified 
resistive training device and then issued a fully intact device as explained in the original methods 
and informed consent form. Each was instructed again in the proper use of the device and 
advised that this newly issued resistive respiratory training device will provide for a greater 
resistance when used in the same fashion as their previously modified devices. All other 
procedures as presented in the original methods and informed consent letter remained unchanged. 
Matthew S. O'Brien, M.Ed., ATC/L 
Primary Investigator 
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OKLAHOMA STATE UNIVERSITY RESEARCH 
LETTER OF CONSENT FORM 
Resistive respiratory training and its effects on the pulmonary mechanics within individuals 
diagnosed with exercise induced asthma 
AUTHORIZATION 
I, (Please clearly print name) , hereby authorize 
Matthew S. O'Brien, M.Ed., ATC, Dr. Michael Davis, DVM, PhD, or Ken Smith, DO to perform 
the following procedures to assess my respiratory function. 
DESCRIPTION OF RESEARCH AND ITS ASSOCIATED RISKS AND BENEFITS 
The Research Project. You are invited to participate in a research study investigating the effects 
of resistive respiratory training on pulmonary function within individuals diagnosed with exercise 
induced asthma. The Principal Investigators are Matthew S. O'Brien, Dr. Ken Smith, DO, 
Oklahoma State University Health Services and Dr. Michael Davis, DVM, PhD, Physiological 
Sciences, Oklahoma State University, Stillwater OK. This invitation has been extended because 
you have expressed interest in participating in a study of your exercise induced asthma. 
Description of project: This six week study has been created to detennine the effectiveness of a 
resistive training device on the pulmonary function of a person diagnosed with exercise induced 
asthma. It is theorized that by limiting the amount of air one can inhale and exhale, the muscles 
that control the breathing process will undergo some training effect much like resistive weight 
training for the musculoskeletal system. It is hoped that the results from this study will introduce 
a new method of controlling the severity of symptoms associated with exercise induced asthma 
and improve lung function in athletes. 
You were invited as a participant in this study because of your diagnosis with exercise induced 
asthma. If you choose to participate in this study, you will be asked to report two (2) different 
times, once at the beginning of the study and once at the end of the five week training period, to a 
testing site in the Seretean Wellness Center, West Farm Road, located on campus. On days of 
testing, it is important that you do not engage in any vigorous exercise or use any rescue inhalers 
for your exercise induced asthma prior to the testing as this will mask potential results. However, 
it is important that you bring any rescue inhalers prescribed to you (for exercise induced asthma) 
from your physician in case you might need them during the testing procedures. On both 
occasions, you will partake in a respiratory measurement that will require you to breath into a 
device that will assess several factors regarding your respiratory function. You will then be 
asked to engage in a seven (7) minute sub-maximal (about 85% of your maximal heart rate) run 
on a standard treadmill. If at any time during the testing procedures you or the investigator feels 
you might pose risk to your health, all testing will be stopped and your participation in the study 
will be excused. At the end of a uncomplicated seven minute run, you will perform the breathing 
measures one more time. At the conclusion of these tests, the primary investigator (Matthew 
O'Brien) will give you a resistive respiratory training device and educate you on its proper use. 
To assure that you do not suffer from any secondary effects of the testing procedures (i.e. severe 
asthmatic attack) we will monitor you while at the testing facility for approximately one hour 
after the treadmill test. You will be asked to follow the protocol requiring you to breath into this 
Initials 
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device for approximately 2 minutes, two times per day for a period of 5 weeks. It is very 
important that you adhere to this protocol as the study's success depends on your compliance. 
IMPORTANT: The resistive respiratory training device used in this study will not substitute for 
a fast acting bronchodilator such as Albuterol®, or Ventolin®. Use your rescue inhaler as 
directed by your physician throughout the course of the five-week training period. 
Duration of the study: This investigation will last approximately six weeks including one for 
testing before and after a five ( 5) week training period. You may, however, withdraw your 
participation from the study at anytime. 
Risks: This study's procedures do not pose any greater risk than you would encounter within 
your participation in collegiate athletics. The seven minute sub-maximal run will resemble a 
moderate running drill within your conditioning program 
In case of injury or illness resulting from participation in the study, the Oklahoma State 
University is not financially responsible for any subsequent medical care. No funds have been set 
aside to compensate subjects medical treatment due to participation. During testing at the 
Seretean Wellness center, a member of the investigation team (Matthew O'Brien) will be present 
to offer any assistance such as cardio-pulmonary resuscitation (CPR) including automatic 
external defibrillation and/or first aid. There will also be a licensed physician on call (Dr. Ken 
Smith) and readily accessible if needed. 
Benefits: You will not be paid for your participation in this study. However, upon successful 
completion of the project, you will be allowed to keep the resistive respiratory training device. 
Also, you will learn several factors regarding your respiratory function such as flow and lung 
volumes. 
Confidentiality: At no time will your name or identity be disclosed in any publication or 
presentation of the results of this study. Only Matthew S. O'Brien, Dr. Ken Smith, DO, OSU 
Health Services and Dr. Michael Davis, DVM, PhD will view any information associated with 
your name obtained through this study regarding your participation. Information kept in hard 
copy or computer form will be secured through locked file cabinets and password protected 
computer software in Matthew O'Brien's locked office. At the conclusion of the study, all paper 
materials and records indicating personal information such as your name will be shredded while 
all computer data will be deleted using a computer program that prevents electronic recovery. 
Although it is impossible to guarantee complete confidentiality throughout the course of this 
study and the time proceeding its conclusion, every reasonable effort will be made to ensure your 
privacy. The federal funding agency (National Institutes of Health), regulatory agencies, and the 
OSU Institutional Review Board have the right to review research protocols. 
Cost: There will be no cost to participate in this investigation. All materials and equipment use 
have been donated. 
Other information: If any significant new fmdings are developed during the course of the 
research that may relate to your willingness to continue participation, we will provide them to 
you. Number of subjects: There will be approximately 24 subjects involved in this study. 
If you have any questions regarding this research study or your participation in it, please feel free 
to contact Matthew S. O'Brien at (405) 744-9439 or matthso@okstate.edu. This research project 
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Subjects 
has been reviewed by the Institutional Review Board of the Oklahoma State University. You may 
request information from this Board about your rights as a research subject or research-related 
injuries. For information on subjects' rights, contact Dr. Carol Olson, Institutional Review Board 
Chair, 415 Whitehurst, 405-744-1676. 
IMPORTANT: The resistive respiratory training device used in this study will not substitute for 
a fast acting bronchodilator such as Albuterol®, or Ventolin®. Use your rescue inhaler as 
directed by your physician throughout the course of the five-week training period. 
VOLUNTARY PARTICIPATION 
Your participation in this study is entirely voluntary. If you decide not to participate, you will not 
be penalized, and you will not lose any benefits or services to which you are otherwise entitled. 
Your decision whether or not to participate will not prejudice your future relations with 
Oklahoma State University. If you decide to participate, you are free to withdraw your consent 
and to stop participating at any time without penalty or loss of benefits to which you are 
otherwise entitled. 
Terminating your participation: If you choose to be part of the study, you will be asked to 
report for the first set of respiratory measurements and then adhere to the training program 
outlined for you. If you decide that you do not wish to participate at any time before the study's 
conclusion, we ask that you inform Matthew S. O'Brien and return the resistive respiratory 
training device. Other circumstances may arise that may impact your participation within this 
study without regard to your consent. If your compliance with the research protocol becomes 
sporadic or if subject population parameters change, your participation may be discontinued. 
If you desire to stop participating, simply inform Matthew S. O'Brien at (405) 744-9439 or 
matthso@okstate.edu. There will be no adverse consequences of your decision to withdraw from 
the project. 
CONSENT DOCUMENTATION 
Participant: I have read and fully understand the consent form. I sign it freely and voluntarily. A 
copy has been given to me. 
Printed Name of Participant Signature of Participant 
Investigator: I certify that I have personally explained all elements of this form to the participant 
before requesting him/ her to sign it. 
Matthew S. O'Brien 
Primary Investigator 
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Exercise-Induced Asthma Screening Questionnaire 
Asthma and Allergy History 
1. Do you have, or have you ever had, asthma? y N 
2. Have you ever had wheezing? y N 
3. Do you have, or have you ever had, allergies to dust, y N 
pollen, or animal dander? 
4. Have you ever had a chronic cough? y N 
5. Do you have nasal polyps, allergic rhinitis, or eczema? y N 
6. Have you ever had shortness of breath, difficulty breathing, y N 
cough, wheezing, chest pain, or chest tightness during or 
after exercise? 
7. If you were to run a kilometer ( about half of a mile), 
would you have to stop to catch your breath y N 
or have trouble breathing afterward? 
8. Do you smoke? y N 
Medical History 
9. Are you currently taking any medication? y N 
If yes, what medication? 
10. Have you had a recent respiratory tract infection? y N 
11. Have you recently received the influenza vaccine? y N 
(Can exacerbate asthma.) 
12. Do you have a history of heart disease, abnormal heart y N 
rhythm, or high blood pressure? 
13. Do you have my other medical problem that could be 
worsened with strenuous activity? y N 
If yes, what conc;lition(s)? 
14. Does anyone in your family have asthma? y N 
Adapted from Feinstein RA, LaRussa J, Wang-Doh/man A, et al: Screening adolescent 
athletes/or exercise-induced asthma. Clin J Sport Med 1996;6(2):119-123 
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BORG'S RATINGS OF PERCEIVED EXERTION SCALE 
6 No Exertion at all 
7 
Very, very light 
8 
9 Very Light 
10 
11 Fairly Light 
12 
13 Somewhat hard 
14 
15 Hard, Heavy 
16 
17 Very Hard 
18 
19 Extremely Hard 
20 MAXIMAL EXERTION 
~ 
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RESPIRATORY TRAINING 
Resistance Sunday Monday Tuesday Wednesday Thursday Friday Saturday 
INHALE 
EXHALE 
Weekl 
I= 1 E= 1 
Week2 
1=2 E=2 
Week3 
1=3 E=3 
Week4 
1=4 E=4 
Week5 
1=4 E=5 
Ifnecess. 
1=4 E= 5 
Training Tips 
1. Use lips, NOT teeth to grip the SportsBreather®. 
2. INHALE for 3-4 seconds, EXHALE for 5 seconds. 
3. If you feel faint or begin to cough during training, stop, let the symptoms subside and 
continue. 
4. THIS DEVICE SHOULD NOT BE USED IN PLACE OF A FAST ACTING 
BRONCHODILATOR. 
5. Use ONLY the device you were assigned. 
I will call every Friday of the training period to make sure you are experiencing no 
problems with the device or training. 
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Study Factors and Categories 
PRE-EXERCISE STRESS TESTING (BASELINE) 
Experimental I Control 
Pre-Training I Post- Training I Pre-Training I Post- Training 
POST-EXERCISE STRESS TESTING <RESPONSE) 
Experimental Control 
Pre- Training I Post- Training Pre-Training I Post- Training 
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t-tests for Randomization 
Independent Samples Test 
Levene's Test for 
Equality of 
Variances t-test for Eaualit1 of Means 
95% Confidence 
Interval of the 
Sig. Mean Std. Error Difference 
F Sia. t df (2-tailed) Difference Difference Lower Uooer 
A_Z_5HZ 1.455 .255 .353 10 .731 .4250 1.20244 -2.25421 3.10421 
A_R_5HZ .962 .350 .351 10 .733 .3962 1.12962 -2.12069 2.91319 
A R_20HZ .742 .409 .348 10 .735 .2575 .73965 -1.39054 1.90554 
A_X_5HZ 5.384 .043 -.320 10 .756 -.1525 .47697 -1.21526 .91026 
A_FVC 3.766 .081 2.279 10 .046 1.2325 .54070 .02774 2.43726 
A_FEV_1 .842 .380 1.499 10 .165 .8987 .59953 -.43708 2.23458 
AFEV1FVC 1.568 .239 -.390 10 .705 -2.4438 6.26291 -16.39839 11.51089 
A_PEF .360 .562 1.019 10 .332 1.9063 1.87142 -2.26354 6.07604 
AFEF2575 .499 .496 .305 10 .767 .2938 .96423 -1.85469 2.44219 
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Hypothesis 1: Baseline Spirometry Group & Training Measures 
FVC 
Group Pre- training Post- training 
1 2.88 3.26 
FVC 1 4.07 3.77 
Group Pre-training Post- training 1 4.75 4.39 
0 3.90 3.69 1 4.86 5.24 
0 6.17 6.98 1 4.17 4.18 
0 4.87 4.78 1 4.16 3.48 
0 6.61 6.32 1 4.90 5.04 
Mean 5.39 5.44 1 3.83 3.88 
SD 1.24 1.49 Mean 4.20 4.16 
SD .67 .71 
FEVl 
Group Pre- training Post- training 
FEVl 1 2.18 .72 
Group Pre- training Post- training 1 2.38 3.20 
0 2.44 .90 1 3.77 1.29 
0 5.00 4.84 1 4.60 4.80 
0 4.16 3.96 1 3.87 2.15 
0 5.34 5.33 1 3.64 3.44 
Mean 4.24 3.76 1 3.28 3.85 
SD 1.30 1.99 1 2.97 3.38 
Mean 3.34 2.85 
SD .80 1.36 
FEV/FVC 
Group Pre- training Post- training 
FEVl/FVC 1 71.15 66.51 
Group Pre- training Post- training 1 65.58 83.39 
0 66.35 76.44 1 86.89 81.93 
0 82.08 71.39 1 92.55 91.30 
0 82.88 82.97 1 94.53 53.67 
0 80.77 83.33 1 85.29 85.15 
Mean 78.02 78.53 1 68.47 77.87 
SD 7.83 5.72 1 79.25 87.18 
Mean 80.46 78.38 
SD 11.10 12.42 
PEF 
Group Pre- training Post- traininir 
PEF 1 5.09 1.79 
Group Pre- training Post- training 1 2.94 5.39 
0 2,97 1.54 1 7.47 3.49 
0 7.95 7.82 1 10.85 10.64 
0 7.99 6.40 1 5.95 3.24 
0 13.16 6.71 1 7.36 7.19 
Mean 8.02 5.62 1 4.61 5.74 
SD 4.16 2.79 1 4.62 6.41 
Mean 6.11 5.49 
SD 2.43 2.75 
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FEF25/75 
Group Pre-treatment Post-treatment 
FEF25/75 1 1.46 .41 
Groun Pre-treatment Post-treatment 1 1.63 3.46 
0 1.71 .65 1 4.11 1.13 
0 4.70 3.56 1 5.91 6.08 
0 3.87 3.90 1 5.28 1.14 
0 4.80 5.76 1 4.04 3.98 
Mean 3.77 3.47 1 2.75 3.45 
SD 1.44 2.11 1 2.63 3.67 
Mean 3.48 2.92 
SD 1.63 1.89 
Tests of Within-Subjects Effects 
Measure: MEASURE 1 
Type Ill Sum 
Source of Sauares df Mean Square F Sia. 
FVC Sphericity Assumed 1.853 1 1.853 2.498 .145 
FVC * GROUP Sphericity Assumed 1.505E-02 1 1.505E-02 .020 .890 
Error(FVC) Sphericity Assumed 7.416 10 .742 
Tests of Within-Subjects Effects 
Measure: TIME 
Type Ill Sum 
Source of Sauares df Mean Sauare F Sia. 
FEV1 Sphericity Assumed 1.229 1 1.229 2.023 .185 
FEV1 * GROUP Sphericity Assumed 3.333E-05 1 3.333E-05 .000 .994 
Error(FEV1) Sphericity Assumed 6.074 10 .607 
Tests of Within-Subjects Effects 
Measure· TIME 
Type Ill Sum 
Source of Sauares df Mean Square F Sia. 
FEV1 FVC Sphericity Assumed 3.313 1 3.313 .028 .871 
FEV1_FVC * GROU Sphericity Assumed 9.022 1 9.022 .076 .788 
Error(FEV1_FVC) Sphericity Assumed 1186.193 10 118.619 
Tests of Within-Subjects Effects 
Measure: TIME 
Type Ill Sum 
Source of Sauares df Mean Sauare F Sia. 
PEF Sphericity Assumed 12.201 1 12.201 3.774 .081 
PEF * GROUP Sphericity Assumed 4.201 1 4.201 1.299 .281 
Error(PEF) Sphericity Assumed 32.329 10 3.233 
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Tests of Within-Subjects Effects 
Measure· TIME 
Type Ill Sum 
Source of Sauares df Mean Sauare F Sia. 
FEV25 75 Sphericity Assumed .995 1 .995 .611 .452 
FEV25 75 * GROUI Sphericity Assumed 8.927E-02 1 8.927E-02 .055 .820 
Error(FEV25 75) Sphericity Assumed 16.268 10 1.627 
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Hypothesis 2: Response Spirometry Group & Training Measures 
FVC Response(% of pre-exercise) 
Group Pre- training Post- training Difference 
FVC Response(% of pre-exercise) 1 94.12 299.08 204.96 
Group Pre-training Post- training Difference 1 112.12 98.18 -13.94 
0 105.98 312.71 206.73 1 109.45 277.85 168.4 
0 101.31 102.95 1.64 1 97.79 99.81 2.02 
0 97.21 106.94 9.73 1 101.71 104.24 2.53 
0 100.00 98.90 -1.1 1 97.42 86.14 -11.28 
Mean 101.12 155.38 54.26 1 102.08 102.02 -0.06 
SD 3.66 104.94 101.28 1 102.13 100.00 -2.13 
Mean 102.10 145.91 43.81 
SD 6.08 88.33 82.25 
FEVl Response(% of pre-exercise) 
Group Pre- training Post- training Difference 
FEVl Response(% of pre-exercise) 1 89.45 386.11 296.66 
Grouo Pre- training Post- training Difference 1 100.84 100.63 -0.21 
0 127.46 303.33 175.87 1 98.94 296.90 197.96 
0 98.60 100.00 1.4 1 68.91 97.92 29.01 
0 91.11 96.97 5.86 1 103.10 126.98 23.88 
0 103.56 102.06 -1.5 1 93.96 88.08 -5.88 
Mean 105.18 150.59 45.41 1 118.60 104.94 -13.66 
SD 15.71 101.85 86.14 1 106.06 100.89 -5.17 
Mean 97.48 162.80 65.32 
SD 14.42998 113.37 98.94002 
FEV/FVC Response(% of pre-exercise) 
Group Pre- training Post- training Difference 
FEVl/ FVC Resoonse (% of pre-exercise) 1 95.17 127.95 32.78 
Group Pre- training Post- training Difference 1 90.01 102.28 12.27 
0 120.24 96.85 -23.39 1 100.68 106.53 5.85 
0 99.00 97.10 -1.9 1 70.45 99.32 28.87 
0 94.35 96.81 2.46 1 101.20 127.59 26.39 
0 106.81 103.28 -3.53 1 98.79 102.33 3.54 
Mean 105.10 98.51 -6.59 1 116.53 102.90 -13.63 
SD 11.33 3.18 -8.15 1 105.03 100.88 -4.15 
Mean 97.23 108.72 11.49 
SD 13.29 11.93 -1.36 
PEFR esponse (o/t f . ) o o pre-exercise 
Group Pre- training Post- training Difference 
PEF R esponse (o/t f . ) o o pre-exercise 1 90.18 401.12 310.94 
Group Pre- training Post- training Difference 1 105.78 93.88 -11.9 
0 184.18 306.49 122.31 1 91.70 197.99 106.29 
0 97.48 112.66 15.18 1 53.27 108.18 54.91 
0 74.47 120.31 45.84 1 119.16 109.88 -9.28 
0 89.51 130.85 41.34 1 95.52 97.08 1.56 
Mean 111.41 167.58 56.17 1 134.92 115.68 -19.24 
SD 49.44 92.91 43.47 1 144.37 104.84 -39.53 
Mean 104.36 153.58 49.22 
SD 28.80 105.42 76.62 
102 
FEF 25/ 75Response (% of baseline) FEF 25/ 75 Response(% of baseline) 
Group Pre- training Post- training Difference Group Pre- training Post- training Difference 
0 153.80 332.31 178.51 l 78.77 700.00 621.23 
0 100.21 83.71 -16.5 l 130.06 106.36 -23.7 
0 88.11 85.64 -2.47 l 102.92 364.60 261.68 
0 119.79 105.56 -14.23 l 37.56 98.85 61.29 
Mean 115.48 151.80 36.32 l 93.75 176.32 82.57 
SD 28.69 120.74 92.05 1 89.85 79.90 -9.95 
l 129.45 99.71 -29.74 
l 109.51 107.90 -1.61 
Mean 96.48 216.70 120.22 
SD 29.91 216.26 186.35 
Tests of Within-Subjects Effects 
Measure: MEASURE 1 
-
Type Ill Sum 
Source of Squares df Mean Square F Sia. 
FVC Sphericity Assumed 12821.898 1 12821.898 2.968 .116 
FVC * GROUF Sphericity Assumed 145.285 1 145.285 .034 .858 
Error(FVC) Sphericity Assumed 43207.424 10 4320.742 
Tests of Within-Subjects Effects 
Measure: MEASURE 1 
Type Ill Sum 
Source of Squares df Mean Square F Sia. 
FEV1 Sphericity Assumed 16349.057 1 16349.057 2.784 .126 
FEV1 * GROUF Sphericity Assumed 528.597 1 528.597 .090 .770 
Error(FEV1) Sphericity Assumed 58720.810 10 5872.081 
Tests of Within-Subjects Effects 
Measure: MEASURE 1 
Type Ill Sum 
Source of Sauares df Mean Square F SiQ. 
FEV1FVC Sphericity Assumed 31.973 1 31.973 .273 .613 
FEV1 FVC * GROL Sphericity Assumed 436.062 1 436.062 3.719 .083 
Error(FEV1 FVC) Sphericity Assumed 1172.413 10 117.241 
Tests of Within-Subjects Effects 
Measure: MEASURE 1 
Type Ill Sum 
Source of Sauares df Mean Square F SiQ. 
PEF Sphericity Assumed 14808.075 1 14808.075 2.957 .116 
PEF * GROUP Sphericity Assumed 64.437 1 64.437 .013 .912 
Error(PEF) Sphericity Assumed 50082.659 10 5008.266 
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Tests of Within-Subjects Effects 
Measure: MEASURE 1 
Type Ill Sum 
Source of Squares df Mean Square F Sia. 
FEF2575 Sphericity Assumed 32674.515 1 32674.515 1.729 .218 
FEF2575 * GROUI Sphericity Assumed 9384.974 1 9384.974 .497 .497 
Error(FEF2575) Sphericity Assumed 188986.879 10 18898.688 
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Hypothesis 3: RPE, Group & Training 
Tests of Within-Subjects Effects 
Measure· MEASURE 1 
iType Ill Sum 
Source of Sauares df Mean Sauare F Sia. 
RPE Sphericity Assume< 49.527 1 49.527 2.294 .161 
RPE * GROUP Sphericity Assumec 19.527 1 19.527 .904 .364 
Error(RPE) Sphericity Assumec 215.920 10 21.592 
TIME Sphericity Assumec 375.869 6 62.645 46.692 .000 
TIME* GROUP Sphericity Assumec 24.583 6 4.097 3.054 .011 
Error(TIME) Sphericity Assumec 80.500 60 1.342 
RPE *TIME Sphericity Assumec 2.536 6 .423 .711 .642 
RPE *TIME* GROI Sphericity Assumec 6.869 6 1.145 1.927 .091 
Error(RPE*TIME) Sphericity Assumec 35.643 60 .594 
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Change in RPE, Group & Training 
Tests of Within-Subjects Effects 
Measure: MEASURE 1 
Type Ill Sum 
Source of Sauares df Mean Sauare F Sia. 
RPE Sphericity Assumed 5.071 6 .845 .711 .642 
RPE*GROUP Sphericity Assumed 13.738 6 2.290 1.927 .091 
Error(RPE) Sphericity Assumed 71.286 60 1.188 
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Hypothesis 4: Response Oscillometry Group & Training 
Z at 5 Hz Response (% of pre-exercise) 
Group Pre-treatment Post-treatment Difference 
Z at 5 Hz Resnonse (% of pre-exercise) 1 106.44 129.11 22.67 
Groun Pre-treatment Post-treatment Difference 1 118.93 110.23 -8.7 
0 87.70 175.96 88.26 1 121.87 141.21 19.34 
0 123.51 137.54 14.03 1 103.52 110.61 7.09 
0 108.01 129.63 21.62 1 124.07 106.32 -17.75 
0 111.95 92.71 -19.24 1 104.71 115.90 11.19 
Mean 107.79 133.96 26.17 1 152.09 102.06 -50.03 
SD 14.92 34.14 19.22 1 88.64 93.65 5.01 
Mean 115.03 113.63 -1.4 
SD 19.00 15.18 -3.82 
R at 5 Hz Response (% of pre-exercise) 
Groun Pre-treatment Post-treatment Difference 
R at 5 Hz Response (% of pre-exercise) 1 151.40 132.85 -18.55 
Group Pre-treatment Post-treatment Difference 1 124.07 109.07 -15 
0 89.95 300.80 210.85 1 127.76 143.75 15.99 
0 122.36 141.59 19.23 1 112.95 120.56 7.61 
0 107.46 134.64 27.18 1 122.14 109.67 -12.47 
0 117.37 95.71 -21.66 1 107.46 118.40 10.94 
Mean 109.29 168.19 · 58.9 1 150.82 102.93 -47.89 
SD 14.30 90.69 76.39 1 87.53 97.83 10.3 
Mean 123.02 116.88 -6.14 
SD 21.40 15.42 -5.98 
R at 20 Hz Response (o/. f . ) o o • pre-exercise 
Group Pre-treatment Post-treatment Difference 
R at 20 Hz Response (% of pre-exercise) 1 100.76 148.16 47.4 
Groun Pre-treatment Post-treatment Difference 1 118.77 118.55 -0.22 
0 90.32 105.98 15.66 1 124.11 142.99 18.88 
0 125.39 136.67 11.28 1 102.48 111.44 8.96 
0 105.70 115.53 9.83 1 117.18 113.20 -3.98 
0 115.61 96.62 -18.99 1 110.71 120.25 9.54 
Mean 109-.26 113.70 4.44 1 158.11 112.82 -45.29 
SD 14.96 17.15 2.19 1 95.59 108.21 12.62 
Mean 115.96 121.95 5.99 
SD 19.67 15.13 -4.54 
X at 5 Hz Resnonse (% of ore-exercise) 
Group Pre-treatment Post-treatment Difference 
X at 5 Hz Response (% of pre-exercise) 1 369.55 124.64 -244.91 
Group Pre-treatment Post-treatment Difference 1 97.39 129.17 31.78 
0 73.83 129.28 55.45 1 59.84 113.33 53.49 
0 150.98 119.59 -31.39 1 83.06 80.67 -2.39 
0 117.58 87.83 -29.75 1 134.48 119.08 -15.4 
0 84.71 82.14 -2.57 1 91.87 93.97 2.1 
Mean 106.78 104.71 -2.07 1 181.97 88.24 -93.73 
SD 34.85 23.23 -11.62 1 132.95 93.97 -38.98 
Mean 143.89 105.38 -38.51 
SD 98.71 18.33 -80.38 
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Tests of Within-Subjects Effects 
Measure· MEASURE 1 
Type Ill Sum 
Source of Squares df Mean Sauare F Sia. 
Z5HZ Sphericity Assumed 818.073 1 818.073 1.628 .231 
Z5HZ * GROUF Sphericity Assumed 1013.271 1 1013.271 2.016 .186 
Error(Z5HZ) Sphericity Assumed 5026.206 10 502.621 
Tests of Within-Subjects Effects 
Measure: MEASURE 1 
Type Ill Sum 
Source of Sauares df Mean Square F Sia. 
RSHZ Sphericity Assumed 3712.492 1 3712.492 2.096 .178 
R5HZ * GROUF Sphericity Assumed 5639.106 1 5639.106 3.184 .105 
Error(R5HZ) Sphericity Assumed 17709.006 10 1770.901 
Tests of Within-Subjects Effects 
Measure: MEASURE 1 
Type Ill Sum 
Source of Squares df Mean Square F Sia. 
R20HZ Sphericity Assumed 145.169 1 145.169 .531 .483 
R20HZ * GROUF Sphericity Assumed 3.183 1 3.183 .012 .916 
Error(R20HZ) Sphericity Assumed 2732.711 10 273.271 
Tests of Within-Subjects Effects 
Measure· MEASURE 1 
-
Type Ill Sum 
Source of Squares df Mean Sauare F Sia. 
X5HZ Sphericity Assumed 2194.935 1 2194.935 .651 .439 
X5HZ * GROUF Sphericity Assumed 1770.726 1 1770.726 .525 .485 
Error(X5HZ) Sphericity Assumed 33738.133 10 3373.813 
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Hypothesis 5: Response Spirometry, Experimental Group & Training 
FVCR esponse . ) ('Y< f o o pre-exercise FEVl R esponse (o/c f . ) o o pre-exercise 
Group Pre-training Post- training Difference Group Pre- training Post- training Difference 
1 94.12 299.08 204.96 1 89.45 386.11 296.66 
1 112.12 98.18 -13.94 1 100.84 100.63 -0.21 
1 109.45 277.85 168.4 1 98.94 296.90 197.96 
1 97.79 99.81 2.02 1 68.91 97.92 29.01 
1 101.71 104.24 2.53 1 103.10 126.98 23.88 
1 97.42 86.14 -11.28 1 93.96 88.08 -5.88 
1 102.08 102.02 -0.06 1 118.60 104.94 -13.66 
1 102.13 100.00 -2.13 1 106.06 100.89 -5.17 
Mean 102.10 145.91 43.81 Mean 97.48 162.80 65.32 
SD 6.08 88.33 82.25 SD 14.42998 113.37 98.94002 
FEV/FVC Response(% of pre-exercise) PEF Response . ) (o/c f o o pre-exercise 
Group Pre- training Post- training Difference Group Pre- training Post- training Difference 
1 95.17 127.95 32.78 1 90.18 401.12 310.94 
1 90.01 102.28 12.27 1 105.78 93.88 -11.9 
1 100.68 106.53 5.85 1 91.70 197.99 106.29 
1 70.45 99.32 28.87 1 53.27 108.18 54.91 
1 101.20 127.59 26.39 1 119.16 109.88 -9.28 
1 98.79 102.33 3.54 1 95.52 97.08 1.56 
1 116.53 102.90 -13.63 1 134.92 115.68 -19.24 
1 105.03 100.88 -4.15 1 144.37 104.84 -39.53 
Mean 97.23 108.72 11.49 Mean 104.36 153.58 49.22 
SD 13.29 11.93 -1.36 SD 28.80 105.42 76.62 
FEF 25/ 75 Response(% of baseline) 
Group Pre- training Post- training Difference 
1 78.77 700.00 621.23 
1 130.06 106.36 -23.7 
1 102.92 364.60 261.68 
1 37.56 98.85 61.29 
1 93.75 176.32 82.57 
1 89.85 79.90 -9.95 
1 129.45 99.71 -29.74 
1 109.51 107.90 -1.61 
Mean 96.48 216.70 120.22 
SD 29.91 216.26 186.35 
Paired Samples Test: Response Spirometry, Experimental Group & Training 
Paired Differences 
95% Confidence 
Interval of the 
Std. Error Difference 
Mean Std. Deviation Mean Lower Upoer t df Sio. (2-tailed) 
Pair 1 %FEV1 - %FEV _ 1 
-65.3220 116.32461 41.12696 162.5718 31.9278 -1.588 7 .156 
Pair2 %FVC-%FVC -43.8124 88.92228 31.43877 118.1533 30.5285 -1.394 7 .206 
Pair3 %FEV1 FVC - %FEVF\ -11.4907 16.68767 5.89998 -25.4419 2.4606 -1.948 7 .092 
Pair4 %PEF-%PEF -49.2167 115.74756 40.92294 145.9841 47.5507 -1.203 7 .268 
Pairs %FEF2575 - %FEF25/ 120.2204 223.89586 79.15914 307.4020 66.9613 -1.519 7 .173 
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